“The Dark Side of Musculoskeletal Care”: Why Do Ineffective Techniques Seem to Work? A Comprehensive Review of Complementary and Alternative Therapies
Abstract
:1. Introduction
2. Methodology of Literature Search
Eligibility Criteria
3. Biological Plausibility of CAMs
3.1. Biological Plausibility of Osteopathy
3.2. Biological Plausibility of Chiropractic
4. Clinical Effectiveness of Osteopathy and Chiropractic in Musculoskeletal Care
4.1. Clinical Effectiveness of Osteopathy
4.2. Clinical Effectiveness of Chiropractic
5. Effects and Potential Mechanisms of Osteopathy and Chiropractic in Musculoskeletal Pain
5.1. Specific Factors in Osteopathic and Chiropractic Practices for Musculoskeletal Care
5.2. Placebo Response: Interaction Between Non-Specific and Contextual Factors in Osteopathic and Chiropractic Practices for Musculoskeletal Care
5.3. Cognitive-Mediated Effects and Bias in Osteopathic and Chiropractic Practices for Musculoskeletal Care
5.4. The Effects Mediated by Context in Osteopathic and Chiropractic Practices for Musculoskeletal Care
5.5. Neurobiological Basis of Contextual Effects in Osteopathic and Chiropractic Practices for Musculoskeletal Care
6. Ethical Considerations of the Effects Mediated by Context and Placebo as First-Line Musculoskeletal Therapy
7. Implication for Clinical Practice
Limitations
8. Conclusions and Future Perspectives
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
Appendix A. Biological Plausibility of CAMs
Author (Year) | Study Type | CAMs | Population | Outcomes and Limitations |
Crow WT et al. (2009) [31] | Observational study | Osteopathy | Human calvarial structures | Outcomes: |
Statistically significant changes in cranial area. | ||||
Changes above the resolution threshold of the MRI scanner (0.898 mm/pixel). | ||||
Limitations: | ||||
Limited resolution of the MRI scanner used. | ||||
Small sample size (20 participants). | ||||
Mirtz et al. (2009) [42] | Epidemiological Review | Chiropractic | General chiropractic | Outcomes: |
Evaluated chiropractic subluxation using Hill’s causation criteria, concluding it lacks validity as a disease cause. | ||||
Limitations: | ||||
Based on theoretical application without experimental data; potentially subjective interpretations. | ||||
Homola (2013) [40] | Commentary/Review | Chiropractic | General chiropractic | Outcomes: |
Critiqued the concept of “vertebral manipulation” in chiropractic, pointing out lack of scientific evidence for “vertebral subluxation”. | ||||
Limitations: | ||||
No original research data provided. | ||||
Findings are interpretive and based on existing literature, introducing potential bias. | ||||
Homola (2016) [41] | Narrative review | Pediatric chiropractic | Pediatric population | Outcomes: |
Criticized “vertebral subluxation” concept in pediatric chiropractic care, emphasizing lack of scientific support. | ||||
Discussed potential health risks for children and need for appropriate medical referral. | ||||
Limitations: | ||||
No original research data provided. | ||||
Findings are interpretive and based on existing literature, introducing potential bias. | ||||
Horton (2015) [33] | Clinical review | Visceral Mobilization therapy (VMT) | General population, focused on pelvic dysfunctions | Outcomes: |
Identified potential clinical applications of VMT in treating genitourinary dysfunction. | ||||
Outlined some clinical evidence supporting VMT for genitourinary and pelvic dysfunction. | ||||
Limitations: | ||||
Evidence limited primarily to case reports and observational studies. | ||||
Lacks robust clinical and experimental trials. | ||||
Effectiveness for specific conditions remains speculative. | ||||
Proposed biological mechanisms lack empirical support. | ||||
Côté P et al. (2020) [38] | Commentary/Review | Chiropractic | General population | Outcomes: |
Data linking chiropractic manipulation to immune system are unreliable. | ||||
Lack of biological plausibility in relationship between chiropractic manipulation and immune system. | ||||
Limitations: | ||||
Does not provide new experimental data on biological mechanisms, relying on previous reviews and expert opinions. | ||||
Nim et al. (2021) [43] | Systematic review | Spinal manipulation | Patients with spinal pain | Outcomes: |
No significant difference between targeted and non-targeted manipulation sites, suggesting specificity may not impact treatment effectiveness. | ||||
Limitations: | ||||
Limited by small number of studies (10) and high variability in study designs. | ||||
Differences in patient populations and protocols impact consistency of findings. | ||||
Requena-García J et al. (2021) [32] | Educational Model validation | Cranial osteopathy | Students learning cranial osteopathy | Outcomes: |
Relationship found between therapist experience and reliability in palpating cranial movements. | ||||
Limitations: | ||||
Use of cadaveric model limits transferability to real clinical situations. | ||||
Variations in cranial movement, measured in microns, probably not perceptible by therapists. | ||||
Consorti G et al. (2023) [37] | Conceptual/Theoretical study | Somatic dysfunction | General population | Outcomes: |
Presents an enactive theoretical framework on “osteopathic dysfunction”. | ||||
Limitations: | ||||
Lacks evidence on proposed potential neurobiological mechanisms. | ||||
Does not establish clear relationship between proposed mechanisms and clinical situation. | ||||
Bordoni B, Escher AR. (2023) [30] | Review | Cranial osteopathy | General population | Outcomes: |
Inconsistencies in PRM theory highlighted. | ||||
Cerebrospinal fluid (CSF) movement is inhomogeneous both centrally and peripherally. | ||||
Limitations: | ||||
No evidence that CSF movement is detectable by palpation. | ||||
Strong suspicion that spheno-occipital synchondrosis is incapable of moving sacrum. | ||||
Hidalgo D et al. (2024) [35] | Narrative review | Osteopathy | Not applicable | Outcomes: |
Examines concept of “anatomical possibilism” in osteopathy. | ||||
Argues this approach may lead to unsupported diagnostic and treatment practices. | ||||
Emphasizes need for osteopathic interventions based on rigorous scientific evidence. | ||||
Limitations: | ||||
Lacks empirical data and relies on theoretical critique, which may introduce interpretative bias. |
Appendix B. Clinical Effectiveness of Osteopathy and Chiropractic in Musculoskeletal Care
Author (Year) | Study Type | Musculoskeletal Care Practice | Population | Outcomes and Limitations |
Ernst (2008) [68] | Evaluation of chiropractic practices, focusing on spinal manipulation and subluxation concepts | Chiropractic care | General population | Outcomes: |
Chiropractic care, particularly spinal manipulation, has been associated with frequent mild adverse effects and rare severe complications. | ||||
Subluxation and spinal manipulation lack scientific backing. | ||||
Spinal manipulation has only shown effectiveness for back pain. | ||||
Many chiropractors treat non-musculoskeletal conditions without proven efficacy. | ||||
The therapeutic value of chiropractic remains unproven beyond reasonable doubt. | ||||
Limitations: | ||||
Lack of empirical evidence for effectiveness beyond back pain. | ||||
Incidence of severe complications from spinal manipulation is unknown. | ||||
The review relies on existing literature, lacking new empirical data. | ||||
No evidence for cost-effectiveness of chiropractic care. | ||||
Gross et al. (2010) [63] | Systematic review | Cervical manipulation and mobilization for neck pain | Adults with neck pain | Outcomes: |
Moderate quality evidence showed that cervical manipulation and mobilization produced similar effects on pain, function, and patient satisfaction at intermediate-term follow-up. | ||||
Low quality evidence suggested cervical manipulation provided greater short-term pain relief than control. | ||||
Low quality evidence also supported thoracic manipulation for pain reduction and improved function in acute pain and chronic neck pain. | ||||
Optimal technique and dose need to be determined. | ||||
Limitations: | ||||
Low quality evidence for some outcomes. | ||||
Methodological quality of studies varied (33% had low risk of bias). | ||||
Limited evidence on the optimal technique and dose for manipulation and mobilization. | ||||
Walker et al. (2010) [64] | Systematic review | Combined chiropractic interventions | Adults with chronic low back pain | Outcomes: |
Chiropractic interventions improved short- and medium-term pain and disability in acute and subacute LBP compared to other therapies. | ||||
No significant difference for long-term pain or disability. | ||||
Small improvements in short-term disability with chiropractic interventions compared to other therapies. | ||||
No difference for chronic LBP. | ||||
Limitations: | ||||
Studies with high risk of bias. | ||||
Small improvements in outcomes, with no clinically meaningful difference compared to other treatments. | ||||
Limited evidence for chronic LBP and mixed populations. | ||||
Need for better quality trials. | ||||
Rubinstein et al. (2011) [150] | Systematic review and meta-analysis | Spinal manipulative therapy (SMT) for chronic low back pain | Adults with chronic low back pain | Outcomes: |
High-quality evidence suggests SMT has a small, statistically significant but not clinically relevant effect on pain relief and functional status in the short term compared to other interventions. | ||||
Varying evidence for the effectiveness of SMT when added to other interventions. | ||||
Very low-quality evidence for SMT’s efficacy compared to inert or sham SMT. | ||||
Limitations: | ||||
No evidence of serious complications, but limited data on recovery, return-to-work, quality of life, and costs of care. | ||||
Inconsistent quality of evidence for various outcomes. | ||||
Sparse data on long-term effects and overall cost-effectiveness. | ||||
High heterogeneity and variability in the studies. | ||||
Ernst (2012) [67] | Review | Chiropractic spinal manipulation | Patients with musculoskeletal and non-musculoskeletal conditions. | Outcomes: |
Cautiously positive evidence for chiropractic spinal manipulation in treating low back pain and neck pain. | ||||
Negative results for non-spinal conditions such as asthma and dysmenorrhoea. | ||||
Cochrane reviews generally considered reliable but show limited evidence for effectiveness in certain conditions. | ||||
Limitations: | ||||
Clinical and statistical heterogeneity across studies prevented meta-analysis. | ||||
Limited evidence for non-spinal conditions. | ||||
Heterogeneity in the included studies made it difficult to draw definitive conclusions. | ||||
Ernst (2012) [52] | Systematic review | Craniosacral therapy (CST) | Various disorders | Outcomes: The review found that CST showed no substantial evidence of effectiveness for any condition. While low-quality studies suggested potential positive effects, the high-quality trial did not demonstrate any significant benefits. Limitations: The review included six studies, most of which had a high risk of bias. The methodological quality was generally poor, with only one study of higher quality. The positive effects suggested by low-quality studies were not corroborated by higher-quality trials, leading to doubts about the validity of CST’s clinical benefits. |
Ajimsha et al. (2013) [59] | Randomized controlled trial | Myofascial release | Nursing professionals with chronic lower back pain | Outcomes: |
MFR showed greater improvement in pain and disability compared to the control group. | ||||
MFR group had a 53.3% reduction in pain and 29.7% reduction in disability at week 8, with continued improvement at week 12. | ||||
73% of MFR group had ≥50% pain reduction. | ||||
Limitations: | ||||
Single-blind design could introduce bias. | ||||
No placebo for control group, only sham MFR. | ||||
Small sample size (80 participants). | ||||
The study did not address long-term effects beyond 12 weeks. | ||||
The control group received sham MFR, which may not fully mimic the standard care. | ||||
Franke et al. (2014) [47] | Systematic review and meta-analysis | Osteopathic manipulative treatment (OMT) | Adults with non-specific low back pain | Outcomes: Moderate-quality evidence showed OMT significantly improved pain and functional status in acute and chronic nonspecific LBP. Limitations: Low evidence quality limits generalizability. The small number of included trials limits robustness. Future research requires larger, high-quality randomized controlled trials (RCTs) with robust control groups. |
Guillaud et al. (2016) [53] | Systematic review | Craniosacral therapy (CST) | Various disorders | Outcomes: |
Diagnostic procedures used in cranial osteopathy are unreliable in many cases. | ||||
For efficacy, the review found that the studies had significant methodological flaws, with only three studies showing low risk of bias. | ||||
These studies failed to rule out non-specific effects, and no strong evidence supported the efficacy of cranial osteopathy. | ||||
Limitations: | ||||
Diagnostic reliability, there was inconsistency in the results, indicating a lack of reliability in cranial osteopathy diagnostics. The methodological quality of the included studies was generally low. | ||||
High risk of bias. | ||||
Low quality of the studies. | ||||
The heterogeneity in study designs and methodologies may limit the generalizability of the findings. | ||||
Arguisuelas et al. (2017) [60] | Randomized controlled trial | Myofascial release | Adults with nonspecific chronic low back pain | Outcomes: |
Significant improvements in pain (SF-MPQ) and sensory subscale, compared to sham MFR. | ||||
Disability and fear-avoidance beliefs significantly decreased in the MFR group compared to the control. | ||||
No differences in VAS scores between groups. | ||||
Limitations: | ||||
The clinical relevance of the improvements is uncertain due to the 95% CI overlapping the minimal clinically important differences. | ||||
The study was limited to a small sample size (54 participants). | ||||
Short duration of the intervention (4 sessions). | ||||
Lack of long-term follow-up data. | ||||
Kranenburg HA et al. (2018) [69] | Systematic review | Cervical spine manipulation (CSM) and mobilization | Patients with neck pain and headache | Outcomes: |
Identified characteristics of patients, practitioners, treatment process, and adverse events (AE). | ||||
Cervical arterial dissection (CAD) reported in 57% of cases, with women more at risk. | ||||
Limitations: | ||||
Poor description of patient characteristics and under-reporting of cases. | ||||
Further research needed for uniform AE registration using standardized terminology. | ||||
Rubinstein SM et al. (2019) [65] | Systematic review and meta-analysis | Spinal manipulative therapy (SMT) | Patients with chronic low back pain | Outcomes: |
SMT produces similar effects to recommended therapies for short-term pain relief and moderate improvement in function. | ||||
Compared to non-recommended therapies, SMT shows a small to moderate improvement in function but minimal pain relief. | ||||
Evidence for sham SMT is of low quality, suggesting uncertain effects. | ||||
Musculoskeletal adverse events were transient and mild to moderate in severity. | ||||
Limitations: | ||||
High heterogeneity between studies made it difficult to interpret some findings. | ||||
Evidence for the effectiveness of sham SMT was of very low quality. | ||||
Most studies did not systematically report adverse events. | ||||
Some results were not clinically relevant despite statistical significance. comparisons, heterogeneity in comparison treatments. | ||||
Rehman et al. (2020) [48] | Systematic review and meta-analysis | Osteopathic manual therapy (OMT) | Patients with chronic pain | Outcomes: |
Some improvement in pain and functional outcomes findings limited by inconsistent methodologies. | ||||
OMT demonstrated no significant impact compared to physiotherapy or gabapentin for any measured outcomes. | ||||
Limitations: | ||||
Small sample sizes. | ||||
Variability in techniques and outcomes. | ||||
Heterogeneity among comparator treatments and outcome measures reduces generalizability. | ||||
Farra et al. (2021) [49] | Systematic review and meta-analysis | Osteopathic interventions (OMT, MFR, CST, OVM) | Patients with chronic non-specific low back pain | Outcomes: |
Osteopathic interventions are more effective than control treatments in reducing pain and improving functional status. | ||||
Myofascial release (MFR) showed the most effective results for pain reduction, with moderate-quality evidence. | ||||
Osteopathic manipulative treatment (OMT) showed a low-quality effect in pain reduction. | ||||
Craniosacral therapy (CST) and osteopathic visceral manipulation (OVM) showed limited evidence for efficacy. | ||||
Limitations: | ||||
None of the studies were judged at low risk of bias (RoB). | ||||
Low to very-low-quality evidence for some treatments, particularly for OMT and CST. | ||||
Limited diversity in osteopathic treatment types, which hinders generalization of findings. | ||||
Further high-quality trials are needed to better compare different osteopathic techniques. | ||||
Nguyen et al. (2021) [61] | Randomized clinical trial | Osteopathic manipulative treatment (OMT) | Adults with nonspecific subacute or chronic low back pain (LBP) | Outcomes: |
The standard OMT group showed a mean reduction in LBP-specific activity limitations of −4.7 points (Quebec Back Pain Disability Index) at 3 months, significantly better than sham OMT group (−1.3 points). | ||||
No significant difference in pain reduction at 3 and 12 months. | ||||
Serious adverse events reported in both groups but not related to OMT. | ||||
Limitations: | ||||
The effect of OMT on LBP-specific activity limitations is small and its clinical relevance is questionable. | ||||
No significant differences found for secondary outcomes such as pain and quality of life. | ||||
The study lacks long-term efficacy data, and the sham OMT may not fully replicate standard OMT in terms of patient expectations. | ||||
Farra et al. (2022) [50] | Systematic review and meta-analysis | Osteopathic manipulative treatment (OMT) | Adults with non-specific neck pain | Outcomes: |
Osteopathic interventions showed statistically significant improvements in pain levels and functional status compared to no intervention or sham treatments. | ||||
Limitations: | ||||
Small sample sizes. | ||||
Difficulty standardizing techniques. | ||||
Evidence quality was rated as “very low.” | ||||
Lotfi et al. (2023) [51] | Literature review | Osteopathic manipulative teatment (OMT) | Patients with irritable bowel syndrome (IBS) | Outcomes: |
The review suggested that OMT may reduce IBS symptoms such as abdominal pain, bloating, and irregular bowel movements. Improvements were attributed to potential modulation of visceral function and nervous system responses. | ||||
Limitations: | ||||
Evidence relied on a small number of studies with varying methodologies and quality. | ||||
Lack of high-quality RCTs and limited generalizability. | ||||
The findings were based on limited and mixed evidence. | ||||
Ceballos-Laita et al. (2023) [58] | Systematic review and meta-analysis | Visceral osteopathy | Adults with low back pain | Outcomes: |
Visceral osteopathy did not show significant improvements in pain intensity, disability or physical function. | ||||
High heterogeneity found in the pain intensity outcome. | ||||
Limitations: | ||||
High risk of bias in the included studies. | ||||
Lack of high-quality studies evaluating the effectiveness of visceral osteopathy for LBP. | ||||
The small number of studies included (5 studies, 268 patients) and heterogeneity in outcomes limit the reliability of conclusions. | ||||
Buffone et al. (2023) [55] | Systematic review and meta-analysis | Osteopathic manipulative treatment (OMT) | Irritable bowel syndrome (IBS) | Outcomes: |
OMT showed statistically significant improvement in abdominal pain and constipation, with effect sizes. | ||||
OMT was not superior to control for other IBS symptoms such as severity of IBS, Likert scale ratings, and diarrhea. | ||||
The quality of evidence was deemed “low” for abdominal pain and constipation, and “very low” for diarrhea. | ||||
The evidence did not support the superiority of OMT for all IBS symptoms, | ||||
OMT was found to be safe with no major adverse effects. | ||||
Limitations: | ||||
The methodological quality of the included studies was generally low. | ||||
High risk of bias. | ||||
Low quality of the studies. | ||||
The heterogeneity in study designs and methodologies may limit the generalizability of the findings. | ||||
Silva et al. (2023) [54] | Systematic review | Visceral fascial therapy | Patients with visceral dysfunctions | Outcomes: |
Visceral Fascial Therapy showed effectiveness in reducing pain in patients with low back pain when combined with standard physical therapy, and in reducing gastroesophageal reflux symptoms in the short term. | ||||
Limitations: | ||||
High risk of bias. | ||||
Low quality of the studies. | ||||
The heterogeneity in study designs and methodologies may limit the generalizability of the findings. | ||||
The evidence for the effectiveness of Fascial Therapy targeting visceral dysfunctions remains insufficient to support widespread clinical use. | ||||
Ceballos-Laita et al. (2024) [56] | Systematic review and meta-analysis | Craniosacral therapy | Various disorders | Outcomes: |
CST produced no statistically significant or clinically relevant changes in pain or disability for musculoskeletal disorders like headache, neck pain, low back pain, pelvic girdle pain, and fibromyalgia. | ||||
CST was also ineffective for non-musculoskeletal disorders like infant colic, cerebral palsy, and visual function deficits. | ||||
Limitations: | ||||
While the literature searches were thorough, it is impossible to ensure no relevant studies were missed. | ||||
The inclusion of a wide range of diverse conditions complicates the interpretation of the results and weakens the strength of the conclusions. | ||||
There was considerable heterogeneity across the included RCTs in terms of treatment duration and outcome variables, which may limit the validity of the quantitative syntheses. | ||||
Bonanno et al. (2024) [28] | Scoping review | Osteopathic manipulative treatment (OMT) | Healthy individuals and patients with chronic musculoskeletal pain | Outcomes: |
OMT appears to influence brain activity in healthy individuals and more significantly in patients with chronic musculoskeletal pain. The review includes studies involving fMRI, EEG, and brain connectivity analysis. | ||||
Limitations: | ||||
Limited number of included studies with mixed designs (RCTs, pilot studies, and crossover studies). | ||||
Studies had variable methodologies and sample sizes. | ||||
More high-quality RCTs are needed to confirm the findings on brain activity and neurophysiological effects of OMT. | ||||
Carrasco-Uribarren et al. (2024) [149] | Systematic review and meta-analysis | Craniosacral therapy | Patients with headache disorders | Outcomes: |
Craniosacral therapy resulted in a statistically significant but clinically unimportant change in pain intensity. | ||||
No significant change in disability or headache effect. | ||||
Very low certainty of evidence. | ||||
Limitations: | ||||
The evidence quality was downgraded to very low. | ||||
Small number of studies (4 studies) with a limited sample size. | ||||
Pain reduction was statistically significant but clinically irrelevant. | ||||
No significant effects on disability or headache effect. | ||||
Farra et al. (2024) [76] | A comprehensive mapping review | Osteopathic manipulative treatment (OMT) | General population with various conditions | Outcomes: |
The review found biological effects induced by OMT, particularly neurophysiological and musculoskeletal changes. | ||||
Limitations: | ||||
Significant variability in study designs, participant conditions, OMT protocols, and documented biological effects. | ||||
The diverse nature of the studies complicates the ability to draw definitive conclusions. | ||||
The review suggests the need for further research to clarify whether these changes are specifically due to OMT and to corroborate their clinical implication. | ||||
Ceballos-Laita et al. (2024) [57] | Systematic review and meta-analysis | Visceral osteopathy | Patients with various musculoskeletal and non-musculoskeletal conditions | Outcomes: |
Visceral osteopathy showed no significant improvement in musculoskeletal conditions such as low back pain, neck pain, or urinary incontinence. | ||||
No effect was found for non-musculoskeletal conditions like irritable bowel syndrome, breast cancer, or preterm infants. | ||||
Studies had high risk of bias and low-to-very low certainty of evidence. | ||||
Limitations: | ||||
Most studies were at high risk of bias. | ||||
Certainty of evidence was downgraded to low or very low. | ||||
No statistically significant changes in outcomes. | ||||
Positive results in non-musculoskeletal conditions were based on flawed studies. | ||||
Many studies did not report adverse events. |
Appendix C. Effects and Potential Mechanisms of Osteopathy and Chiropractic in Musculoskeletal Pain: Placebo Response: Interaction Between Non-Specific and Contextual Factors in Osteopathic and Chiropractic Practices for Musculoskeletal Care
Author (Year) | Study Type | Mechanism and Effect Placebo | Population | Outcomes and Limitations |
Benedetti et al. (2005) [140] | Narrative review | Neurobiological mechanisms of placebo effect | General population | Outcomes: |
Identified several neurobiological mechanisms underlying placebo effects. | ||||
Highlighted the role of opioid and non-opioid neurotransmitter systems in placebo analgesia. | ||||
Described how placebo effects can modulate various physiological systems beyond pain, including motor performance and immune responses. | ||||
Limitations: | ||||
The complexity of placebo mechanisms makes it challenging to isolate specific factors. | ||||
Many studies cited were conducted in experimental settings, which may not fully reflect clinical realities. | ||||
The review doesn’t address potential differences in placebo mechanisms across different medical conditions or populations. | ||||
Eippert (2009) [88] | Experimental | Descending modulation mechanisms in placebo analgesia | Healthy volunteers | Outcomes: |
Placebo analgesia is associated with increased activity in the dorsolateral prefrontal cortex, rostral anterior cingulate cortex, and periaqueductal gray matter. | ||||
This activation was reversed by the opioid antagonist naloxone, indicating the involvement of endogenous opioids. | ||||
The study provided indirect evidence that opioidergic descending pain control circuits underlie placebo analgesia. | ||||
Limitations: | ||||
Relatively small sample size. | ||||
The study was conducted on healthy volunteers, which may limit generalizability to clinical pain conditions. | ||||
The use of experimental pain may not fully reflect chronic pain experiences. | ||||
The study focused on short-term effects and did not address long-term placebo responses. | ||||
Schweinhardt et al. (2009) [89] | Experimental | Placebo analgesia and personality traits | Healthy volunteers | Outcomes: |
The study suggests that the anatomy of the mesolimbic reward system may predispose individuals to placebo analgesia. | ||||
Found a correlation between placebo analgesic responses and gray matter density in the mesolimbic reward system: ventral striatum, insula, and medial prefrontal cortex. | ||||
Identified a link between placebo analgesia and personality traits: ego-resiliency and straightforwardness. | ||||
Limitations: | ||||
Small sample size limits generalizability. | ||||
The study was conducted on healthy volunteers, which may not reflect responses in clinical pain populations. | ||||
The correlational nature of the findings limits causal inferences. | ||||
The study focused on brain structure rather than function, which may not capture the full complexity of placebo responses. | ||||
Hróbjartsson, Gøtzsche (2010) [91] | Systematic review and meta-analysis | Placebo interventions for all clinical conditions | Patients with various clinical conditions | Outcomes: |
Found no evidence that placebo interventions have important clinical effects in general. | ||||
Possible small benefits in studies with continuous subjective outcomes and for the treatment of pain. | ||||
In general, no significant effects outcomes. | ||||
Limitations: | ||||
High heterogeneity among studies. | ||||
Difficulty in distinguishing genuine placebo effects from bias. | ||||
Lack of data on harms of placebo interventions. | ||||
Stein et al. (2012) [146] | Experimental | White matter integrity and placebo analgesia | Healthy volunteers | Outcomes: |
Found that white matter integrity of the descending pain modulatory system, particularly in the dorsolateral prefrontal cortex and rostral anterior cingulate cortex, predicted individual differences in placebo analgesia. | ||||
Suggests a neuroanatomical basis for variability in placebo responses. | ||||
Limitations: | ||||
Small sample size. | ||||
Study conducted on healthy volunteers, limiting generalizability to clinical populations. | ||||
Focus on acute experimental pain may not reflect chronic pain conditions. | ||||
Amanzio (2013) [142] | Meta-analysis | Brain connectivity in placebo analgesia | Healthy volunteers | Outcomes: |
Identified consistent activation patterns associated with placebo analgesia, including in the rCCA, CPFDL, and PAG. | ||||
Deactivation was observed in areas processing pain. | ||||
The study supports the involvement of opioid and non-opioid mechanisms in placebo analgesia. | ||||
Limitations: | ||||
Focus on experimental pain in healthy volunteers may limit generalizability to clinical pain. | ||||
Heterogeneity in study designs and analysis methods across included studies. | ||||
The meta-analysis was based on a relatively small number of neuroimaging studies | ||||
Atlas, Wager (2014) [141] | Meta-analysis | Placebo analgesia and expectancy-based pain modulation | Healthy volunteers | Outcomes: |
Consistent placebo-induced reductions in pain-related brain regions (dorsal anterior cingulate, thalamus, insula, amygdala, striatum) | ||||
Increased activation in prefrontal cortex, midbrain, and rCCA. | ||||
Suggests placebo effects impact both pain processing and emotion/value systems. | ||||
Limitations: | ||||
Variability in experimental designs across studies. | ||||
Focus on contrasts rather than correlations with behavior. | ||||
Limited ability to determine causal mechanisms. | ||||
Büchel (2014) [145] | Perspective/Review | Placebo hypoalgesia and predictive coding | N/A (Not applicable) | Outcomes: |
Proposes a hierarchical Bayesian framework based on predictive coding to explain placebo hypoalgesia. | ||||
Suggests that placebo hypoalgesia results from combining top-down prior expectations with bottom-up sensory signals. | ||||
Emphasizes the importance of both the mean and precision of predictions and sensory signals. | ||||
Reframes the ascending and descending pain systems as a recurrent system implementing predictive coding. | ||||
Limitations: | ||||
Conceptual framework, not an empirical study. | ||||
Focuses only on acute pain in healthy individuals. | ||||
Precise neurobiological implementation of the model remains speculative. | ||||
Colloca (2014) [78] | Narrative review | Placebo and nocebo responses in pain management | General population | Outcomes: |
The paper synthesizes mechanisms behind placebo and nocebo effects, particularly in pain management, highlighting the role of cognitive, emotional, and contextual factors in modulating pain perception. | ||||
Neurobiological pathways (e.g., endogenous opioids, dopamine) are explored. | ||||
Limitations: | ||||
The study is a synthesis, lacking direct empirical data. | ||||
It heavily relies on secondary sources, which may introduce bias in interpretation. | ||||
The generalizability of findings across diverse clinical scenarios remains uncertain. | ||||
Peciña, Zubieta (2014) [139] | Narrative review | Molecular mechanisms of placebo responses in humans | Patients with various clinical conditions | Outcomes: |
The study investigates the role of the μ-opioid receptor system in mediating placebo analgesia. | ||||
It identifies specific neurobiological pathways, showing that placebo effects are influenced by the brain’s pain and reward modulation systems. | ||||
The interaction between dopamine and opioid pathways is highlighted in placebo responses. | ||||
Limitations: | ||||
This is a review paper, so it is based on secondary data and may be biased. | ||||
Further research is needed to explore these mechanisms in diverse clinical populations. | ||||
Wager, Atlas (2015) [94] | Review | Neuroscience of placebo effects, focusing on context, learning, and health | General population | Outcomes: |
The review explores neural mechanisms of placebo effects, highlighting the role of the prefrontal cortex, endogenous opioid and dopamine pathways, and the influence of learning and context on treatment outcomes. | ||||
Limitations: | ||||
Lacks new empirical data and focuses broadly on neuroscience, limiting its applicability to specific clinical contexts like musculoskeletal care. | ||||
Further research is needed to validate these mechanisms in diverse settings. | ||||
Cerritelli (2016) [132] | Systematic Review | Placebo/sham therapy in osteopathy | Healthy population and population with different clinical conditions. | Outcomes: |
Evaluation of the application of placebo and sham therapies in osteopathic clinical trials. | ||||
The lack of standardized methods and variability in sham approaches across studies are highlighted. | ||||
High heterogeneity in the design of placebo controls, making clear conclusions on the effectiveness of sham therapies difficult. | ||||
Limitations: | ||||
High risk of bias in studies, particularly in allocation, blinding and selective reporting. | ||||
Variation in sham therapy methodologies and insufficient reported information make it difficult to assess placebo effects in osteopathy. | ||||
A quantitative analysis could not be performed due to these methodological limitations. | ||||
The article highlights the need to develop standardized guidelines for placebo controls in manual medicine trials. | ||||
Testa, Rossettini (2016) [83] | Narrative review | Placebo and nocebo effects in physiotherapy | General population undergoing physiotherapy | Outcomes: |
The review examines the neurobiology of placebo and nocebo effects in physiotherapy. | ||||
It highlights the role of contextual factors, such as the physiotherapist’s and patient’s characteristics, the therapist–patient relationship, and the healthcare environment. | ||||
Contextual factors are identified as key modulators of clinical outcomes. | ||||
Focus is placed on enhancing placebo effects and minimizing nocebo effects in physiotherapy treatments. | ||||
Limitations: | ||||
The review is a narrative synthesis, relying on existing literature without new empirical data. | ||||
It centers on general placebo and nocebo concepts but lacks specific experimental evidence. | ||||
The clinical applicability of the discussed effects in physiotherapy remains unvalidated through direct experimentation. | ||||
Ashar (2017) [92] | Narrative review | Placebo mechanisms and affective appraisal | Not specified | Outcomes: |
This review provides an overview of the placebo effect and its underlying brain mechanisms, particularly how appraisals of treatments influence outcomes. | ||||
It identifies how placebo treatments, including those for pain, engage a core network of brain regions associated with self-evaluation, emotion, and reward processing, within the default mode network. | ||||
The review emphasizes that placebo effects work by modifying how people evaluate their symptoms and future well-being. | ||||
Limitations: | ||||
The review does not introduce new empirical data or clinical trials. | ||||
The generality of the findings, based on cognitive and neural appraisals, limits its direct applicability to specific clinical conditions or populations. | ||||
Beedie et al. (2018) [93] | Editorial | The role of placebo effects in CAM use in sports medicine and physiotherapy | Athletes and practitioners (elite and non-elite) | Outcomes: |
This review discusses the role of placebo and nocebo effects in complementary and alternative medicine (CAM) in sports medicine, emphasizing the complexity and variability of placebo effects. | ||||
It presents placebo mechanisms like dopamine and opioid systems. | ||||
Highlights challenges in using placebo effects to legitimize CAM, including variability, negative placebo effects (nocebo), and ethical concerns around deception. | ||||
Suggests “headroom” mechanisms: the capacity to respond to placebos could indicate reserve capacity for legitimate treatments. | ||||
Limitations: | ||||
The review is based on existing literature and lacks original empirical data. | ||||
Limited to placebo mechanisms, not addressing the full spectrum of CAM effects or evidence. | ||||
Caveats in using placebo mechanisms for CAM are not fully explored, especially with regards to practical application in sports physiotherapy. | ||||
Some recommendations may not be directly applicable across all CAM practices. | ||||
Blasini et al. (2018) [82] | Narrative review | The role of patient-practitioner relationships in placebo and nocebo phenomena | Pain patients (general clinical setting) | Outcomes: |
Identifies the biopsychosocial factors influencing placebo and nocebo effects in the patient-practitioner relationship. | ||||
Emphasizes the role of expectancies and contextual factors (verbal suggestions, conditioning, and social observation) in shaping therapeutic outcomes. | ||||
Found that macro (cultural, societal) and micro (individual psychobiological traits) factors influence expectancies. | ||||
Empathy, friendliness, and competence of the practitioner enhance positive expectancies and placebo effects. | ||||
Patient-practitioner caring and warm interactions improve the therapeutic experience, particularly for pain patients. | ||||
Limitations: | ||||
The review is based on existing literature without new empirical data. | ||||
Focuses on theoretical models, lacking direct experimental evidence in the clinical setting. | ||||
Subjective interpretations and lack of systematic analysis may reduce generalizability of findings across different clinical populations. | ||||
The review does not provide concrete guidelines for integrating these findings into clinical practice. | ||||
Cai, He (2019) [137] | Narrative review | Placebo effects and molecular biological components involved | General clinical setting | Outcomes: |
Summarizes the history and characteristics of placebo effects. | ||||
Identifies key molecular components involved in placebo effects, including the dopamine, opioid, serotonin, and endocannabinoid systems. | ||||
Introduces the concept of placebome, aiming to understand the genetic and molecular basis of placebo effects. | ||||
Discusses placebome studies and the need for no-treatment control (NTC) to identify genetic targets. | ||||
Limitations: | ||||
The placebome concept is still in its early stages. | ||||
Lacks experimental data and new empirical findings. | ||||
No clinical trials were included to test the molecular findings in real clinical settings. | ||||
Emphasizes theoretical bioinformatics analysis rather than practical evidence in the clinical context. | ||||
Need for NTC-controlled placebo studies to validate results and further explore the genetic targets related to placebo effects. | ||||
Anderson, Stebbins (2020) [80] | Narrative review | Determinants of placebo effects and responses | General clinical and research settings | Outcomes: |
Explores intrinsic factors influencing placebo responses, including patient expectations, previous experiences, neural systems under treatment, personality traits, and situational factors. | ||||
Identifies clinician determinants, such as empathy, perceived expertise, clinical relationship quality, and belief in treatment efficacy. | ||||
Analyzes extrinsic factors, such as study design, advertising, branding, and cultural influences, highlighting their combined impact on placebo effects. | ||||
Limitations: | ||||
Provides a theoretical framework without new empirical evidence. | ||||
Focuses on general determinants of placebo effects rather than specific contexts, such as musculoskeletal care. | ||||
Does not evaluate how identified factors quantitatively influence placebo responses in clinical practice or research. | ||||
Crawford et al. (2021) [144] | Experimental study | Brainstem mechanisms involved in placebo analgesia and nocebo hyperalgesia | Healthy volunteers | Outcomes: |
Found altered activity in key pain modulatory brainstem nuclei during placebo and nocebo responses. | ||||
Identified distinct recruitment of the PAG-RVM pathway during greater placebo analgesia and nocebo hyperalgesia. | ||||
Demonstrated differential activation of the parabrachial nucleus and overlapping activation in the substantia nigra and locus coeruleus for both effects. | ||||
Suggests that the PAG-RVM pathway influences pain modulation at the level of the dorsal horn. | ||||
Limitations: | ||||
Small sample size (N = 25) limits generalizability of findings. Study focuses on acute experimental pain, reducing relevance to chronic pain scenarios. | ||||
Deceptive conditioning may introduce variability in participants’ responses. | ||||
Findings are correlational, limiting causal inference about brainstem circuitry and pain modulation. | ||||
Shi et al. (2021) [79] | Experimental study | Placebo and nocebo responses in acute lower back pain (ALBP) | Healthy volunteers | Outcomes: |
Significant differences in VAS pain scores observed for placebo and nocebo interventions compared to baseline and between placebo and nocebo groups. | ||||
Placebo network involves negative lagged-temporal correlation between the DLPFC, secondary somatosensory cortex, ACC, and IC. | ||||
Positive correlations were found between IC, thalamus, ACC, and SMA. | ||||
Nocebo network includes positive correlations among primary somatosensory cortex, caudate, DLPFC, and SMA. | ||||
Placebo response engages the reward system, inhibits the pain network, and activates opioid-mediated analgesia and emotion pathways. | ||||
Nocebo response deactivates emotional control and primarily engages pain-related pathways. | ||||
Verified that placebo and nocebo networks share brain regions but also have distinct features. | ||||
Limitations: | ||||
Small sample size (N = 20) limits the generalizability of findings. | ||||
Study was conducted in healthy individuals, which may not reflect responses in clinical populations with chronic pain. | ||||
Correlational nature of findings limits causal interpretations. | ||||
fMRI-based GCA may be influenced by methodological biases, such as signal variability and lag-time estimation. | ||||
Thomson et al. (2021) [95] | Editorial/review | Exploration of contextual factors (CFs) in osteopathy and musculoskeletal care | N/A | Outcomes: |
Highlights the critical role of contextual factors such as clinician habits, patient expectations, therapeutic relationships, and treatment environments in shaping clinical outcomes. | ||||
Suggests CFs influence outcomes via placebo and nocebo effects. | ||||
Discusses the lack of CF awareness in osteopathic education and its implications for enhancing patient outcomes. | ||||
Proposes research directions for better integration and evaluation of CFs in osteopathy and healthcare. | ||||
Limitations: | ||||
The study is narrative and does not include new empirical data or quantitative analysis. | ||||
Limited generalizability due to its focus on osteopathy, though findings may apply broadly. | ||||
Recommendations are theoretical and require further research validation through robust empirical methods. | ||||
Does not specify direct evidence linking CF manipulation to improved outcomes in osteopathy. | ||||
Zunhammer et al. (2021) [148] | Systematic meta-analysis | Neural systems and brain mechanisms underlying placebo analgesia, based on experimental fMRI studies | Healthy volunteers | Outcomes: |
Identifies placebo analgesia as a multifaceted phenomenon involving multiple brain areas, including ventral attention networks (mid-insula), somatomotor networks (posterior insula), thalamus, habenula, mid-cingulate cortex, and supplementary motor area. | ||||
Behavioral placebo analgesia correlates with reduced pain-related activity and increased frontoparietal activity, highlighting mechanisms of nociception, affect, and decision-making in pain. | ||||
Significant between-study heterogeneity suggests variability in cerebral mechanisms across studies. | ||||
Limitations: | ||||
High between-study heterogeneity limits the ability to generalize findings across placebo analgesia contexts. | ||||
Focuses on healthy participants; results may not directly translate to clinical populations with chronic pain. | ||||
While robust at the neural level, behavioral and psychological interpretations of findings are limited. | ||||
Excluded eight eligible studies due to lack of participant-level data, potentially introducing selection bias. | ||||
Bieniek, Bąbel (2023) [86] | Experimental study | Placebo hypoalgesia induced through operant conditioning using verbal, social, and token-based rewards and punishers | Healthy volunteers | Outcomes: |
Placebo hypoalgesia was successfully induced in groups with social and token-based reinforcement, but not with verbal reinforcement alone. | ||||
Expectations of pain mediated the hypoalgesic effect, suggesting cognitive involvement. | ||||
The number of reinforcers received predicted the magnitude of hypoalgesia, highlighting the role of conditioning intensity. | ||||
Findings suggest token-based and social consequences may optimize pain management interventions. | ||||
Limitations: | ||||
Focused on healthy participants, limiting generalizability to clinical populations with chronic pain. | ||||
Did not evaluate the long-term stability of placebo hypoalgesia effects. | ||||
The study lacked diversity in participant demographics, potentially influencing the broader applicability of findings. | ||||
While results highlight conditioning effects, their translation to clinical practice requires further investigation. | ||||
Testa et al. (2023) [84] | Book chapter/review | Management of cognitive, relational, and environmental contextual factors to optimize placebo effects and minimize nocebo effects in clinical practice | General population | Outcomes: |
Contextual factors, including beliefs, expectations, and therapeutic relationships, significantly enhance the outcomes of evidence-based treatments. | ||||
Effective management of negative mindsets through empathic relationships can improve patient experience. | ||||
Clinician’s attitude and skills in addressing contextual effects add measurable value to the therapeutic process. | ||||
Limitations: | ||||
The review provides theoretical guidance but lacks empirical validation of specific strategies for managing contextual factors. | ||||
Generalized conclusions may not apply across all patient populations or clinical settings. | ||||
Limited discussion of practical implementation challenges in clinical practice. | ||||
Colloca et al. (2023) [85] | Book chapter/review | Cultural influences on placebo and nocebo responses, including beliefs, rituals, and healthcare relationships | General population | Outcomes: |
Cultural beliefs, norms, and values shape treatment expectations and responses to placebo and nocebo effects. | ||||
Physical and aesthetic preferences, influenced by culture, affect the perceived efficacy of treatments. | ||||
Spiritual and religious beliefs impact coping strategies and treatment responses. | ||||
Rituals and healthcare provider-patient dynamics (e.g., verbal and nonverbal cues) are critical in shaping placebo/nocebo responses. | ||||
Limitations: | ||||
The review is theoretical and lacks empirical data directly validating the role of cultural factors in placebo/nocebo responses. | ||||
Generalizations are based on broad cultural concepts, which may not capture specific individual or subgroup variations. | ||||
Limited exploration of how cultural factors interact with biological or psychological mechanisms. | ||||
Crawford et al. (2023) [144] | Experimental study | Brain mechanisms of placebo analgesia | Healthy volunteers | Outcomes: |
No significant differences in gamma-aminobutyric acid (GABA) or other metabolites between placebo responders and non-responders in the right DLPFC. | ||||
Identified an inverse relationship between glutamate levels and pain rating variability during conditioning. | ||||
Demonstrated altered functional connectivity between the DLPFC and midbrain periaqueductal gray (PAG) during placebo analgesia. | ||||
Highlighted the role of the DLPFC in shaping stimulus-response relationships during conditioning. | ||||
Limitations: | ||||
The study was conducted on healthy individuals, limiting its applicability to clinical populations. | ||||
The small sample size (38 participants) reduces the generalizability of findings. | ||||
The study focuses only on acute pain scenarios, limiting its relevance to chronic pain contexts. | ||||
Correlational nature of findings does not establish causation between DLPFC activity and placebo response. | ||||
Hartmann et al. (2023) [81] | Experimental study | Empathy-related psychological and structural brain differences between placebo analgesia responders and non-responders | Healthy volunteers | Outcomes: |
Placebo analgesia responders exhibited higher helping behavior and lower psychopathic traits compared to non-responders. | ||||
Responders showed greater pain-related empathic concern. | ||||
Structural brain differences: non-responders had increased gray matter volume in areas like the left inferior temporal and parietal supramarginal cortical regions and increased cortical surface area in the bilateral middle temporal cortex. | ||||
Limitations: | ||||
Uncorrected results in some analyses may lead to overestimated conclusions. | ||||
Focus on a relatively narrow trait-based classification (e.g., empathy, psychopathy) without comprehensive exploration of other individual differences. | ||||
Study paradigm and setting could influence outcomes, suggesting that contextual factors were not fully controlled for. | ||||
Meeuwis et al. (2023) [87] | Systematic Review and Meta-analysis | The effect of observational learning on placebo hypoalgesia and nocebo hyperalgesia | Healthy volunteers | Outcomes: |
Invest Observational learning (OL) had a small-to-medium effect on pain ratings (SMD = 0.44). | ||||
- OL had a large effect on pain expectancy (SMD = 1.11). | ||||
Empathic concern of the observer was positively correlated with the magnitude of placebo/nocebo effects (r = 0.14). | ||||
Type of observation (in-person vs. videotaped) influenced the effect size (p < 0.01). | ||||
Limitations: | ||||
Moderate heterogeneity across studies. | ||||
No clear clinical application of findings in chronic pain populations. | ||||
Lack of placebo type modulation in the results (p = 0.23), suggesting further research is needed to clarify its role. | ||||
Limited exploration of other empathy-related factors beyond empathic concern. | ||||
Rossettini et al. (2023) [138] | State of the art review | Overview of placebo and nocebo effects in experimental and chronic pain | Healthy volunteers and chronic pain patients | Outcomes: |
Strong evidence that placebo and nocebo effects are influenced by the psychosocial context. | ||||
Psychological mechanisms and neurobiological/genetic determinants of placebo and nocebo effects are detailed. | ||||
Differences in the occurrence of these effects between experimental settings (healthy participants) and clinical settings (chronic pain patients). | ||||
Emphasizes the heterogeneity of pain in chronic patients affecting the magnitude of these effects. | ||||
Limitations: | ||||
Heterogeneity of pain in chronic patients makes results difficult to generalize. | ||||
No unified results on the magnitude and occurrence of placebo/nocebo effects in chronic pain patients. | ||||
Lacks specific experimental data to validate the proposed mechanisms in clinical settings. | ||||
Calls for future research to address these gaps and improve the understanding of contextual factors. | ||||
Caliskan et al. (2024) [97] | Clinical update Review | Focus on treatment expectations, placebo/nocebo effects, and contextual factors | Patients in clinical settings, with an emphasis on pain management | Outcomes: |
Treatment expectations significantly influence treatment outcomes, acting as powerful modulators of health outcomes. | ||||
Contextual factors that modify expectations can improve therapy success. | ||||
Placebo analgesia and nocebo hyperalgesia are key mechanisms in the management of pain, with the expectations contributing to the overall treatment success. | ||||
Further research is needed to personalize treatment strategies based on individual patient expectations. | ||||
Limitations: | ||||
The article is a clinical update and relies on existing evidence, with limited experimental data. | ||||
It discusses variability in placebo/nocebo responses but does not identify clear predictors for individual responses. | ||||
Calls for future research to explore personalized approaches to modulating treatment expectations. | ||||
Does not address all clinical conditions in depth beyond pain. | ||||
Pedersen et al. (2024) [96] | Systematic review and meta-analysis | Focus on placebo effects, specific treatment effects, and changes observed without treatment in interventions for chronic nonspecific low back pain (NSLBP) | Adults with chronic nonspecific low back pain (NSLBP) | Outcomes: |
Approximately half of the overall treatment effect in conservative interventions for chronic NSLBP is attributed to changes observed without treatment, with smaller contributions from specific treatment and placebo effects. | ||||
For pain intensity, 33% is attributed to specific treatment effects, 18% to placebo effects, and 49% to no-treatment changes. | ||||
For physical function and HRQoL, 53% and 48% of the effect, respectively, is due to no treatment changes. | ||||
Limitations: | ||||
Low certainty of evidence, suggesting that the true effects might differ significantly from the reported estimates. | ||||
The study is focused on conservative and passive interventions, which limits the applicability to other treatment types. | ||||
The findings are based on short-term treatment effects and may not reflect long-term outcomes. | ||||
Saueressig et al. (2024) [46] | Review and methodological analysis | Focus on the methods used to quantify contextual effects in clinical care, particularly in placebo-controlled studies | N/A | Outcomes: |
The study critiques existing methods for quantifying contextual effects and proposes that the most effective method is comparing a placebo group with a non-treated control group. | ||||
Other methods (such as the placebo control arm alone or proportional contextual effect calculation) are deemed inappropriate. | ||||
This paper aims to provide guidance on best practices for estimating contextual effects in clinical research. | ||||
Limitations: | ||||
The review lacks empirical data as it is a methodological analysis, meaning it does not directly address clinical outcomes or interventions. | ||||
It focuses only on theoretical frameworks and does not provide practical examples or real-world clinical applications. | ||||
The effectiveness of the proposed method has not been fully tested or validated in diverse clinical settings. |
Appendix D. Effects and Potential Mechanisms of Osteopathy and Chiropractic in Musculoskeletal Pain: Cognitive-Mediated Effects and Bias in Osteopathic and Chiropractic Practices for Musculoskeletal Care
Author (Year) | Study Type | Psychological Elements of the CAMs | Population | Outcomes and Limitations |
Forer (1949) [115] | Experimental | Personal validation fallacy | College students | Outcomes: |
Demonstrated how people tend to accept vague, general personality descriptions as accurate. | ||||
Limitations: | ||||
Limited sample, potential experimenter bias. | ||||
Beyerstein (2001) [124] | Review | Reasoning errors in alternative medicine | General population | Outcomes: |
Identified common logical fallacies in CAM beliefs. | ||||
Limitations: | ||||
Lack of empirical data. | ||||
Kaptchuk (2002) [116] | Review | Placebo effect in CAM | General population | Outcomes: |
Discussed potential clinical significance of healing rituals. | ||||
Limitations: | ||||
Lack of original data. | ||||
Winslow, Shapiro (2002) [108] | Cross-sectional survey | Physicians’ attitudes towards CAM education | American physicians | Outcomes: |
Physicians want more CAM education to better communicate with patients. | ||||
Limitations: | ||||
Potential response bias. | ||||
Klein, Helweg-Larsen (2002) [111] | Meta-analysis | Perceived control and optimistic bias | General population | Outcomes: |
Positive correlation between perceived control and optimistic bias. | ||||
Limitations: | ||||
Heterogeneity in included studies. | ||||
The findings may not be generalizable to the use of CAM. | ||||
Honda et al. (2005) [99] | Cross-sectional survey | Personality, coping strategies, and social support in CAM use | American adults | Outcomes: |
Personality traits, coping strategies and social support influence CAM use. | ||||
Limitations: | ||||
Self-reported data, potential recall bias. | ||||
Singh et al. (2005) [113] | Qualitative study is based on in-person interviews | Motivation for CAM use | Men with prostate cancer | Outcomes: |
Identified various motivations for CAM use, including hope and empowerment. | ||||
Limitations: | ||||
Small sample size. | ||||
Limited generalizability to musculoskeletal care. | ||||
Shih et al. (2009) [114] | Cross-sectional survey | CAM usage patterns | Singaporean adult cancer patients | Outcomes: |
High prevalence of CAM use, influenced by cultural factors. | ||||
Limitations: | ||||
Single-center study. | ||||
Potential selection bias. | ||||
Limited generalizability to musculoskeletal care. | ||||
Sperber (2010) [120] | Theoretical review | The “Guru Effect” in alternative beliefs | N/A | Outcomes: |
Proposed mechanism for why people trust incomprehensible ideas from perceived authorities. | ||||
Limitations: | ||||
Lack of empirical testing. | ||||
Wolfe, Michaud (2010) [122] | Observational study | Hawthorne effect in clinical trials | Patients with rheumatoid arthritis (RA) | Outcomes: |
Patients showed improved outcomes during the screening process before receiving any treatment. | ||||
This effect led to an overestimation of treatment efficacy in clinical trials. | ||||
Limitations: | ||||
Study based on observational data, which may limit causal inferences. | ||||
Potential confounders are not fully controlled. | ||||
Generalizability to other conditions or trial designs may be limited. | ||||
Berthelot et al. (2011) [121] | Commentary | Hawthorne effect vs placebo effect | N/A | Outcomes: |
Argued Hawthorne effect may be stronger than placebo in some cases. | ||||
Limitations: | ||||
Limited empirical evidence presented. | ||||
Walach (2013) [90] | Book chapter/review | Placebo effects in CAM | General population | Outcomes: |
Discusses the role of placebo effects in CAM, suggesting that these effects may be particularly strong in CAM due to the holistic approach and strong therapeutic relationships. | ||||
Proposes that CAM might trigger self-healing responses through various contextual and psychological factors. | ||||
Limitations: | ||||
Not peer-reviewed research. | ||||
May lack the rigorous methodology of a systematic review or meta-analysis. | ||||
The generalizability of the conclusions may be limited due to the diverse nature of CAM practices. | ||||
Benedetti et al. (2013) [98] | Experimental | Pain perception and opioid/cannabinoid systems | Healthy volunteers | Outcomes: |
Changing pain meaning from negative to positive activates opioid and cannabinoid systems. | ||||
Limitations: | ||||
Small sample size. | ||||
laboratory setting. | ||||
Yarritu, Matute (2015) [104] | Experimental | Causal illusion in health beliefs | University students | Outcomes: |
Prior knowledge can induce an illusion of causality through biased behavior. | ||||
Limitations: | ||||
Artificial laboratory task. | ||||
Blanco (2017) [102] | Book chapter/Review | Cognitive bias | General population | Outcomes: |
Defined and described various cognitive biases. | ||||
Limitations: | ||||
Not original research. | ||||
Not peer-reviewed research. | ||||
Stub et al. (2017) [118] | Qualitative interviews | Complementary therapists’ reflections on practice | Norwegian CAM practitioners | Outcomes: |
Therapists often refer to “patient healing power” as placebo effect. | ||||
Limitations: | ||||
Small sample. | ||||
Potential social desirability bias. | ||||
Galbraith et al. (2018) [112] | Systematic review | Traits and cognitions associated with CAM use/belief | CAMs user | Outcomes: |
Identified personality traits and cognitive styles linked to CAM use. | ||||
Limitations: | ||||
Heterogeneity in included studies. | ||||
Garrett et al. (2019) [119] | Mixed methods | Perceptions of internet-based health scams | UK adults | Outcomes: |
Identified factors promoting engagement with online health scams. | ||||
Limitations: | ||||
Potential selection bias in online sample. | ||||
Moreno Castro et al. (2019) [101] | Qualitative research methods | Influences on perception of pseudo-therapies | Spanish population | Outcomes: |
Media, social circles, and education influence pseudo-therapy beliefs. | ||||
Limitations: | ||||
Self-reported data, potential social desirability bias. | ||||
Chow et al. (2021) [105] | Experimental | Causal relationships in pseudoscientific health beliefs | University students | Outcomes: |
Perceived frequency of causal relationships influences pseudoscientific beliefs. | ||||
Limitations: | ||||
Artificial laboratory task. | ||||
Rodríguez-Ferreiro et al. (2021) [106] | Experimental | Evidential criteria in pseudoscience believers | Spanish adults | Outcomes: |
Pseudoscience believers have lower evidential criteria. | ||||
Limitations: | ||||
The online sample may not be representative of the general population. | ||||
Self-reported measurements may be subject to bias. | ||||
The study’s correlational nature limits causal inferences about the relationship between evidential criteria and pseudoscientific beliefs. | ||||
Davies et al. (2022) [117] | Systematic review | Knowledge used in CAM consultations | Physicians and patients | Outcomes: |
Classified types of knowledge used in CAM practice. | ||||
Limitations: | ||||
Heterogeneity in included studies. | ||||
Esteves et al. (2022) [100] | Theoretical paper | Osteopathic care as enactive inference | General population | Outcomes: |
Proposed theoretical framework for osteopathic practice. | ||||
Limitations: | ||||
Lack of empirical testing. | ||||
Garcia-Arch et al. (2022) [107] | Experimental | Expert feedback on pseudoscientific beliefs | Spanish adults | Outcomes: |
Expert feedback can increase acceptance of health-related pseudoscientific beliefs. | ||||
Limitations: | ||||
Online sample. | ||||
Artificial task. | ||||
García-Arch et al. (2022) [109] | Correlational | Prediction of pseudoscience acceptance | Spanish adults | Outcomes: |
Information interpretation and individual differences predict pseudoscience acceptance. | ||||
Limitations: | ||||
Cross-sectional design, self-reported data. | ||||
Piñeiro Pérez et al. (2022) [110] | Cross-sectional survey | Pediatricians’ knowledge and use of CAM | Spanish pediatricians | Outcomes: |
Identified gaps in CAM knowledge among pediatricians. | ||||
Limitations: | ||||
Potential response bias. | ||||
Segovia et al. (2022) [9] | Cross-sectional survey | Trust and belief in pseudotherapies | Spanish adults | Outcomes: |
Pseudotherapy use is associated with trust in efficacy rather than belief in scientific validity. | ||||
Limitations: | ||||
Self-reported data. | ||||
Potential social desirability bias. | ||||
Torres et al. (2022) [103] | Experimental | Causal illusion in pseudoscientific beliefs | Spanish university students | Outcomes: |
Information interpretation and search strategies influence causal illusions. | ||||
Limitations: | ||||
It does not allow us to know the causality between the illusions of causality and the tendency to maintain unjustified beliefs. | ||||
There may be variables that are not controlled. | ||||
Vicente et al. (2023) [125] | Experimental | Prior beliefs’ influence on judgments of medicine effectiveness | University students | Outcomes: |
Prior beliefs influence judgments about both alternative and scientific medicine. | ||||
Limitations: | ||||
The online sample may not be representative, which prevents generalization of the results. | ||||
Potential social desirability bias. | ||||
The correlational nature of the study limits causal inferences. | ||||
The study is based on hypothetical scenarios, which may not fully reflect how people would make decisions in real health situations. | ||||
The study cannot fully control for other factors that might influence judgments about the effectiveness of treatments. | ||||
Neogi, Colloca (2023) [123] | Narrative review | Placebo effects in osteoarthritis | Patients with osteoarthritis | Outcomes: |
Placebo effects contribute significantly to pain relief in osteoarthritis. | ||||
These effects are mediated by psychological factors and neurobiological mechanisms. | ||||
Placebo responses may be enhanced by several factors, including the therapeutic encounter, treatment characteristics, and individual patient factors. | ||||
It is suggested that understanding and harnessing placebo effects could improve clinical outcomes and drug development in osteoarthritis. | ||||
Limitations: | ||||
The review is based on existing literature, which may have variable quality and methodologies. | ||||
Generalizability of the findings to all patients with osteoarthritis may be limited. | ||||
The review does not provide new empirical data. | ||||
The long-term effects of placebo responses in osteoarthritis are not well established. |
Appendix E. Effects and Potential Mechanisms of Osteopathy and Chiropractic in Musculoskeletal Pain: The Effects Mediated by Context in Osteopathic and Chiropractic Practices for Musculoskeletal Care
Author (Year) | Study Type | Intervention/Contextual Focus | Population | Outcomes and Limitations |
Kaptchuk (2002) [116] | Narrative review | Placebo Effect in CAM | General population | Outcomes: |
Discusses how ritualistic and symbolic aspects of alternative medicine can evoke clinically significant placebo responses. | ||||
Limitations: | ||||
Primarily theoretical; lacks empirical data to substantiate claims. | ||||
Paterson (2005) [133] | Narrative review | Placebo effect in acupuncture | Acupuncture patients | Outcomes: |
Distinguishes between characteristic and incidental (placebo) effects in acupuncture efficacy. | ||||
Limitations: | ||||
Lacks experimental data, limited generalizability beyond acupuncture. | ||||
Linde et al. (2005) [134] | Randomized Controlled Trial | Acupuncture | Migraine patients | Outcomes: |
The possible benefits of acupuncture may be due to factors other than those derived from the needling. | ||||
Limitations: | ||||
Lack of significant difference with control group suggests influence of non-specific factors. | ||||
Diener et al. (2006) [135] | RCT | Acupuncture | Migraine patients | Outcomes: |
Treatment outcomes for migraine did not differ significantly between verum acupuncture, sham acupuncture, and standard therapy groups, suggesting a strong influence of contextual factors | ||||
Limitations: | ||||
High dropout rate in the standard therapy group (106 patients) may have affected group comparability. | ||||
Inability to blind participants to standard drug therapy could have influenced patient-reported outcomes. | ||||
The study design did not allow for isolation of specific contextual factors from overall treatment effects. | ||||
Fulda et al. (2007) [128] | Pilot study | Osteopathic Manipulative Treatment (OMT) | Low back pain patients | Outcomes: |
Positive expectations can influence perceived efficacy, even in placebo treatments. | ||||
Limitations: | ||||
Small sample size limits generalizability; preliminary findings lack statistical power. | ||||
Lack of control groups reduces the ability to isolate the impact of expectations. | ||||
Meissner et al. (2013) [130] | Systematic review | Placebo in migraine prophylaxis | Migraine patients | Outcomes: |
Efficacy among placebo treatments in preventing migraine. | ||||
Limitations: | ||||
Heterogeneity of included studies may affect consistency of conclusions. | ||||
Calpin et al. (2017) [127] | Comparative retrospective study. | Chronic pain management | Patients with chronic pain | Outcomes: |
Discrepancies in expectations were noted, with significant effects from patient characteristics like age, gender, and sleep quality on expectations. The study highlights the need to align expectations for better outcomes. | ||||
Limitations: | ||||
Small sample of physicians limits generalization. | ||||
Based on descriptive comparisons only. | ||||
Lack of follow-up after consultation. | ||||
Possible misinterpretation of free responses. | ||||
Rossettini et al. (2018) [126] | Narrative review. | Placebo/nocebo in MSK care | Patients with musculoskeletal pain | Outcomes: |
Highlights influence of contextual factors on placebo and nocebo effects. | ||||
Limitations: | ||||
Lacks comprehensive analysis of primary data; broad generalizations may limit applicability. | ||||
Thomson et al. (2021) [95] | Clinical Commentary | Placebo/Contextual factors | General MSK care | Outcomes: |
Emphasizes the importance of contextual factors in enhancing treatment effects. | ||||
Limitations: | ||||
Lacks original data; primarily theoretical commentary. | ||||
Tsutsumi et al. (2023) [136] | Meta-epidemiological study | Contextual effects in general medicine | Data from Cochrane reviews | Outcomes: |
Estimates significant portion of medical treatment results attributable to contextual and placebo effects. | ||||
Limitations: | ||||
Focus on general medicine may limit direct applicability to musculoskeletal care. | ||||
Nim et al. (2025) [131] | Systematic review with network meta-analysis | Spinal manipulative therapy (SMT) application procedures | Adults with spine pain | Outcomes: |
Most SMT procedures were slightly more effective than other treatments; a general and non-specific SMT approach had the highest probability of achieving the largest effects. | ||||
Limitations: | ||||
Differences between SMT approaches were small and not clinically relevant; evidence was of low to very low certainty due to heterogeneity, bias, and lack of direct comparisons |
References
- Kemppainen, L.M.; Kemppainen, T.T.; Reippainen, J.A.; Salmenniemi, S.T.; Vuolanto, P.H. Use of Complementary and Alternative Medicine in Europe: Health-Related and Sociodemographic Determinants. Scand. J. Public Health 2018, 46, 448–455. [Google Scholar] [CrossRef] [PubMed]
- Møller, S.R.; Ekholm, O.; Christensen, A.I. Trends in the Use of Complementary and Alternative Medicine between 1987 and 2021 in Denmark. BMC Complement. Med. Ther. 2024, 24, 23. [Google Scholar] [CrossRef]
- Bishop, F.L.; Yardley, L.; Lewith, G.T. A Systematic Review of Beliefs Involved in the Use of Complementary and Alternative Medicine. J. Health Psychol. 2007, 12, 851–867. [Google Scholar] [CrossRef] [PubMed]
- Johnson, P.J.; Jou, J.; Rockwood, T.H.; Upchurch, D.M. Perceived Benefits of Using Complementary and Alternative Medicine by Race/Ethnicity Among Midlife and Older Adults in the United States. J. Aging Health 2019, 31, 1376–1397. [Google Scholar] [CrossRef] [PubMed]
- Peltzer, K.; Pengpid, S. Prevalence and Determinants of Traditional, Complementary and Alternative Medicine Provider Use among Adults from 32 Countries. Chin. J. Integr. Med. 2018, 24, 584–590. [Google Scholar] [CrossRef]
- MacArtney, J.I.; Wahlberg, A. The Problem of Complementary and Alternative Medicine Use Today: Eyes Half Closed? Qual. Health Res. 2014, 24, 114–123. [Google Scholar] [CrossRef]
- Hestbaeck, L.; Hartvigsen, J.; Christensen, H.; Werner, V. Osteopathy and Chiropractic Treatment in Babies with Infantile Colic. Acta Paediatr. 2023, 112, 2239–2240. [Google Scholar] [CrossRef]
- Lobera, J.; Rogero-García, J.S.A. Homeopathy Determinants of Trust in Complementary and Alternative Medicine. Health Commun. 2020, 36, 1278–1285. [Google Scholar] [CrossRef]
- Segovia, G.; Sanz-Barbero, B. It Works for Me”: Pseudotherapy Use Is Associated With Trust in Their Efficacy Rather Than Belief in Their Scientific Validity. Int. J. Public Health 2022, 67, 1604594. [Google Scholar] [CrossRef]
- Sinclair, A.J.; Sturrock, A.; Davies, B.; Matharu, M. Headache Management: Pharmacological Approaches. Pract. Neurol. 2015, 15, 411–423. [Google Scholar] [CrossRef]
- Weatherall, M. Drug Therapy in Headache. Clin. Med. 2015, 15, 273–279. [Google Scholar] [CrossRef] [PubMed]
- Lipton, R.B.; Serrano, D.; Holland, S.; Fanning, K.M.; Reed, M.L.; Buse, D.C. Barriers to the Diagnosis and Treatment of Migraine: Effects of Sex, Income, and Headache Features. Headache 2013, 53, 81–92. [Google Scholar] [CrossRef] [PubMed]
- Rossi, P.; Lorenzo, G.; Malpezzi, M.; Faroni, J.; Cesarino, F.; Lorenzo, C.; Nappi, G. Prevalence, Pattern and Predictors of Use of Complementary and Alternative Medicine (CAM) in Migraine Patients Attending a Headache Clinic in Italy. Cephalalgia 2005, 25, 493–506. [Google Scholar] [CrossRef] [PubMed]
- Moore, C.S.; Sibbritt, D.W.; Adams, J. A Critical Review of Manual Therapy Use for Headache Disorders: Prevalence, Profiles, Motivations, Communication and Self-Reported Effectiveness. BMC Neurol. 2017, 17, 61. [Google Scholar] [CrossRef]
- Bustins, G.A.; Plaza, P.-V.L.; Carvajal, S.R. Profile of Osteopathic Practice in Spain: Results from a Standardized Data Collection Study. BMC Complement. Altern. Med. 2018, 18, 129. [Google Scholar] [CrossRef]
- WMA Declaration of Cordoba on Patient-Physician Relationship. Available online: https://www.wma.net/policies-post/wma-declaration-of-cordoba-on-patient-physician-relationship/ (accessed on 26 January 2025).
- Danell, J.A.B.; Danell, R.; Vuolanto, P. Fifty Years of Complementary and Alternative Medicine (CAM)—A Bibliometric Analysis of Publication Activity and General Content of the Publications. J. Sci. Res. 2020, 9, 268–276. [Google Scholar] [CrossRef]
- N.I.H. National Center for Complementary and Integrative Health (NCCIH). Obtenido de Complementary, Alternative, or Integrative Health: What’s In a Name? N.I.H. National Center for Complementary and Integrative Health (NCCIH): Bethesda, MD, USA, 2021.
- Pettman, E. A History of Manipulative Therapy. J. Man. Manip. Ther. 2007, 15, 165–174. [Google Scholar] [CrossRef]
- Federspil, G.; Vettor, R. Can scientific medicine incorporate alternative medicine? J. Altern. Complement. Med. 2000, 6, 241–244. [Google Scholar] [CrossRef]
- Rajtmajer, S.M.; Errington, T.M.; Hillary, F.G. How Failure to Falsify in High-Volume Science Contributes to the Replication Crisis. eLife 2022, 11, 78830. [Google Scholar] [CrossRef]
- Palsson, T.S.; Gibson, W.; Darlow, B.; Bunzli, S.; Lehman, G.; Rabey, M.; Moloney, N.; Vaegter, H.B.; Bagg, M.K.; Travers, M. Changing the Narrative in Diagnosis and Management of Pain in the Sacroiliac Joint Area. Phys. Ther. 2019, 99, 1511–1519. [Google Scholar] [CrossRef]
- Tascilar, M.; Jong, F.A.; Verweij, J.; Mathijssen, R.H.J. Complementary and Alternative Medicine during Cancer Treatment: Beyond Innocence. Oncologist 2006, 11, 732–741. [Google Scholar] [CrossRef] [PubMed]
- Gasparyan, A.Y.; Ayvazyan, L.; Blackmore, H.; Kitas, G.D. Writing a Narrative Biomedical Review: Considerations for Authors, Peer Reviewers, and Editors. Rheumatol. Int. 2011, 31, 1409–1417. [Google Scholar] [CrossRef] [PubMed]
- Koterov, A.U. Hill’s “Biological Plausibility” Criterion: Integration of Data from Various Disciplines for Epidemiology and Radiation Epidemiology. Biol. Bull. Russ. Acad. Sci. 2021, 48, 1991–2014. [Google Scholar] [CrossRef]
- Roberts, A.; Harris, K.; Outen, B.; Bukvic, A.; Smith, B.; Schultz, A.; Bergman, S.; Mondal, D. Osteopathic Manipulative Medicine: A Brief Review of the Hands-On Treatment Approaches and Their Therapeutic Uses. Medicines 2022, 9, 33. [Google Scholar] [CrossRef] [PubMed]
- Thomson, O.; MacMillan, A. What’s Wrong with Osteopathy? Int. J. Osteopath. Med. 2023, 48, 100659. [Google Scholar] [CrossRef]
- Bonanno, M.; Papa, G.A.; Ruffoni, P.; Catalioto, E.; Luca, R.; Maggio, M.G.; Calabrò, R.S. The Effects of Osteopathic Manipulative Treatment on Brain Activity: A Scoping Review of MRI and EEG Studies. Healthcare 2024, 12, 1353. [Google Scholar] [CrossRef]
- Ceballos-Laita, L.; Jiménez-Del-Barrio, S.; Carrasco-Uribarren, A.; Medrano-De-La-Fuente, R.; Robles-Pérez, R.; Ernst, E. Is Osteopathic Manipulative Treatment Clinically Superior to Sham or Placebo for Patients with Neck or Low-Back Pain? A Systematic Review with Meta-Analysis. Diseases 2024, 12, 287. [Google Scholar] [CrossRef]
- Bordoni, B.; Escher, A.R. The Osteopath’s Imprint: Osteopathic Medicine Under the Nanoscopic Lens. Cureus 2023, 15, 33914. [Google Scholar] [CrossRef]
- Crow, W.T.; King, H.H.; Patterson, R.M.; Giuliano, V. Assessment of Calvarial Structure Motion by MRI. Osteopath. Med. Prim. Care 2009, 3, 8. [Google Scholar] [CrossRef]
- Requena-García, J.; García-Nieto, E.; Varillas-Delgado, D. Objectivation of an Educational Model in Cranial Osteopathy Based on Experience. Medicina 2021, 57, 246. [Google Scholar] [CrossRef]
- Horton, R. The Anatomy, Biological Plausibility and Efficacy of Visceral Mobilization in the Treatment of Pelvic Floor Dysfunction. J. Pelvic Obstet. Gynaecol. Physiother. 2015, 117, 5–18. [Google Scholar]
- Cazzola, D.; Alberti, G.; Ongaro, L.; Minetti, A.E. The Vertical Excursion of the Body Visceral Mass during Vertical Jumps Is Affected by Specific Respiratory Maneuver. Hum. Mov. Sci. 2014, 33, 369–380. [Google Scholar] [CrossRef]
- Hidalgo, D.F.; MacMillan, A.; Thomson, O.P. It’s All Connected, so It All Matters’’—The Fallacy of Osteopathic Anatomical Possibilism. Int. J. Osteopath. Med. 2024, 52, 100718. [Google Scholar] [CrossRef]
- Guillaud, A.; Darbois, N.; Monvoisin, R.; Pinsault, N. Reliability of Diagnosis and Clinical Efficacy of Visceral Osteopathy: A Systematic Review. BMC Complement. Altern. Med. 2018, 18, 65. [Google Scholar] [CrossRef] [PubMed]
- Consorti, G.; Castagna, C.; Tramontano, M.; Longobardi, M.; Castagna, P.; Lernia, D.; Lunghi, C. Reconceptualizing Somatic Dysfunction in the Light of a Neuroaesthetic Enactive Paradigm. Healthcare 2023, 11, 479. [Google Scholar] [CrossRef]
- Côté, P.; Bussieres, A.; Cassidy, J.D.; Hartvigsen, J.; Kawchuk, G.N.; Leboeuf-Yde, C.; Mior, S.; Schneider, M.; Aillet, L.; Ammendolia, C. A United Statement of the Global Chiropractic Research Community against the Pseudoscientific Claim That Chiropractic Care Boosts Immunity. Chiropr. Man. Ther. 2020, 28, 21. [Google Scholar] [CrossRef]
- Haas, A.; Chung, J.; Kent, C.; Mills, B.; McCoy, M. Vertebral Subluxation and Systems Biology: An Integrative Review Exploring the Salutogenic Influence of Chiropractic Care on the Neuroendocrine-Immune System. Cureus 2024, 16, 56223. [Google Scholar] [CrossRef]
- Homola, S. Pseudoscience in the Use of Manipulation by Chiropractors. Focus Altern. Complement. Ther. 2013, 18, 89–94. [Google Scholar] [CrossRef]
- Homola, S. Pediatric Chiropractic Care: The Subluxation Question And Referral Risk. Bioethics 2016, 30, 63–68. [Google Scholar] [CrossRef]
- Mirtz, T.A.; Morgan, L.; Wyatt, L.H.; Greene, L. An Epidemiological Examination of the Subluxation Construct Using Hill’s Criteria of Causation. Chiropr. Osteopat. 2009, 17, 13. [Google Scholar] [CrossRef]
- Nim, C.G.; Downie, A.; O’neill, S.; Kawchuk, G.N.; Perle, S.M.; Leboeuf-Yde, C. The Importance of Selecting the Correct Site to Apply Spinal Manipulation When Treating Spinal Pain: Myth or Reality? A Systematic Review. Sci. Rep. 2021, 11, 23415. [Google Scholar] [CrossRef]
- Johansen, M.K.; Osman, M. Coincidence Judgment in Causal Reasoning: How Coincidental Is This? Cogn. Psychol. 2020, 120, 101290. [Google Scholar] [CrossRef] [PubMed]
- Ezzatvar, Y.; Dueñas, L.; Balasch-Bernat, M.; Lluch-Girbés, E.; Rossettini, G. Which Portion of Physiotherapy Treatments’ Effect Is Not Attributable to the Specific Effects in People with Musculoskeletal Pain? A Meta-Analysis of Randomized Placebo-Controlled Trials. J. Orthop. Sports Phys. Ther. 2024, 54, 391–399. [Google Scholar] [CrossRef] [PubMed]
- Saueressig, T.; Pedder, H.; Owen, P.J.; Belavy, D.L. Contextual Effects: How to, and How Not to, Quantify Them. BMC Med. Res. Methodol. 2024, 24, 35. [Google Scholar] [CrossRef] [PubMed]
- Franke, H.; Franke, J.-D.; Fryer, G. Osteopathic Manipulative Treatment for Nonspecific Low Back Pain: A Systematic Review and Meta-Analysis. BMC Musculoskelet. Disord. 2014, 15, 286. [Google Scholar] [CrossRef]
- Rehman, Y.; Ferguson, H.; Bozek, A.; Blair, J.; Allison, A.; Johnston, R. Osteopathic Manual Treatment for Pain Severity, Functional Improvement, and Return to Work in Patients With Chronic Pain. J. Am. Osteopath. Assoc. 2020, 120, 888–906. [Google Scholar] [CrossRef]
- Farra, F.D.; Risio, R.G.; Vismara, L.; Bergna, A. Effectiveness of Osteopathic Interventions in Chronic Non-Specific Low Back Pain: A Systematic Review and Meta-Analysis. Complement. Ther. Med. 2021, 56, 102616. [Google Scholar] [CrossRef]
- Farra, F.D.; Buffone, F.; Risio, R.G.; Tarantino, A.G.; Vismara, L.; Bergna, A. Effectiveness of Osteopathic Interventions in Patients with Non-Specific Neck Pain: A Systematic Review and Meta-Analysis. Complement. Ther. Clin. Pract. 2022, 49, 101655. [Google Scholar] [CrossRef]
- Lotfi, C.; Blair, J.; Jumrukovska, A.; Grubb, M.; Glidden, E.; Toldi, J. Effectiveness of Osteopathic Manipulative Treatment in Treating Symptoms of Irritable Bowel Syndrome: A Literature Review. Cureus 2023, 15, 42393. [Google Scholar] [CrossRef]
- Ernst, E. Craniosacral Therapy: A Systematic Review of the Clinical Evidence. Focus. Altern. Complement. Ther. 2012, 17, 197–201. [Google Scholar] [CrossRef]
- Guillaud, A.; Darbois, N.; Monvoisin, R.; Pinsault, N. Reliability of Diagnosis and Clinical Efficacy of Cranial Osteopathy: A Systematic Review. PLoS ONE 2016, 11, 167823. [Google Scholar] [CrossRef] [PubMed]
- Silva, F.C.; Vieira, L.S.; Santos, L.V.; Gaudreault, N.; Cruvinel-Júnior, R.H.; Santos, G.M. Effectiveness of Visceral Fascial Therapy Targeting Visceral Dysfunctions Outcome: Systematic Review of Randomized Controlled Trials. BMC Complement. Med. Ther. 2023, 23, 274. [Google Scholar] [CrossRef] [PubMed]
- Buffone, F.; Tarantino, A.G.; Belloni, F.; Spadafora, A.; Bolzoni, G.; Bruini, I.; Bergna, A.; Vismara, L. Effectiveness of Osteopathic Manipulative Treatment in Adults with Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. Healthcare 2023, 11, 2442. [Google Scholar] [CrossRef] [PubMed]
- Ceballos-Laita, L.; Ernst, E.; Carrasco-Uribarren, A.; Cabanillas-Barea, S.; Esteban-Pérez, J.; Jiménez-Del-Barrio, S. Is Craniosacral Therapy Effective? A Systematic Review and Meta-Analysis. Healthcare 2024, 12, 679. [Google Scholar] [CrossRef]
- Ceballos-Laita, L.; Ernst, E.; Carrasco-Uribarren, A.; Esteban-Tarcaya, G.; Mamud-Meroni, L.; Jiménez-del-Barrio, S. Is Visceral Osteopathy Therapy Effective? A Systematic Review and Meta-Analysis. Int. J. Osteopath. Med. 2024, 54, 100729. [Google Scholar] [CrossRef]
- Ceballos-Laita, L.; Mingo-Gomez, M.T.; Medrano-de-la-Fuente, R.; Hernando-Garijo, I.; Jimenez-del-Barrio, S. The Effectiveness of Visceral Osteopathy in Pain, Disability, and Physical Function in Patients with Low-Back Pain. A Systematic Review and Meta-Analysis. Explore 2023, 19, 195–202. [Google Scholar] [CrossRef]
- Ajimsha, M.; Daniel, B.; Chithra, S. Effectiveness of Myofascial Release in the Management of Chronic Low Back Pain in Nursing Professionals. J. Bodyw. Mov. Ther. 2014, 18, 273–281. [Google Scholar] [CrossRef]
- Arguisuelas, M.D.; Lisón, J.F.; Sánchez-Zuriaga, D.; Martínez-Hurtado, I.; Doménech-Fernández, J. Effects of Myofascial Release in Nonspecific Chronic Low Back Pain. Spine 2017, 42, 627–634. [Google Scholar] [CrossRef]
- Nguyen, C.; Boutron, I.; Zegarra-Parodi, R.; Baron, G.; Alami, S.; Sanchez, K.; Daste, C.; Boisson, M.; Fabre, L.; Krief, P. Effect of Osteopathic Manipulative Treatment vs. Sham Treatment on Activity Limitations in Patients With Nonspecific Subacute and Chronic Low Back Pain: A Randomized Clinical Trial. JAMA Intern. Med. 2021, 181, 620–630. [Google Scholar] [CrossRef]
- Rotter, G.; Fernholz, I.; Binting, S.; Keller, T.; Roll, S.; Kass, B.; Reinhold, T.; Willich, S.N.; Schmidt, A.; Brinkhaus, B. The Effect of Osteopathic Medicine on Pain in Musicians with Nonspecific Chronic Neck Pain: A Randomized Controlled Trial. Ther. Adv. Musculoskelet. Dis. 2020, 12. [Google Scholar] [CrossRef]
- Gross, A.; Miller, J.; D’sylva, J.; Burnie, S.J.; Goldsmith, C.H.; Graham, N.; Haines, T.; Brønfort, G.; Hoving, J.L. Manipulation or Mobilisation for Neck Pain: A Cochrane Review. Man. Ther. 2010, 15, 315–333. [Google Scholar] [CrossRef]
- Walker, B.F.; French, S.D.; Grant, W.; Green, S. Combined Chiropractic Interventions for Low-Back Pain. Cochrane Database Syst. Rev. 2010, 5427. [Google Scholar] [CrossRef]
- Rubinstein, S.M.; Zoete, A.; Middelkoop, M.; Assendelft, W.J.J.; Boer, M.R.; Tulder, M.W. Benefits and Harms of Spinal Manipulative Therapy for the Treatment of Chronic Low Back Pain: Systematic Review and Meta-Analysis of Randomised Controlled Trials. BMJ 2019, 364, 689. [Google Scholar] [CrossRef]
- Gevers-Montoro, C.; Provencher, B.; Descarreaux, M.; Mues, A.O.; Piché, M. Clinical Effectiveness and Efficacy of Chiropractic Spinal Manipulation for Spine Pain. Front. Pain Res. 2021, 2, 765921. [Google Scholar] [CrossRef] [PubMed]
- Ernst, E. Chiropractic Spinal Manipulation: What Does the “Best” Evidence Show? Focus Altern. Complement. Ther. 2012, 17, 202–206. [Google Scholar] [CrossRef]
- Ernst, E. Chiropractic: A Critical Evaluation. J. Pain Symptom Manag. 2008, 35, 544–562. [Google Scholar] [CrossRef]
- Kranenburg, H.; Schmitt, M.; Puentedura, E.; Luijckx, G.; Schans, C. Adverse Events Associated with the Use of Cervical Spine Manipulation or Mobilization and Patient Characteristics: A Systematic Review. Musculoskelet. Sci. Pract. 2017, 28, 32–38. [Google Scholar] [CrossRef] [PubMed]
- Hohenschurz-Schmidt, D.; Thomson, O.P.; Rossettini, G.; Miciak, M.; Newell, D.; Roberts, L.; Vase, L.; Draper-Rodi, J. Avoiding Nocebo and Other Undesirable Effects in Chiropractic, Osteopathy and Physiotherapy: An Invitation to Reflect. Musculoskelet. Sci. Pract. 2022, 62, 102677. [Google Scholar] [CrossRef]
- Bishop, M.D.; Beneciuk, J.M.; George, S.Z. Immediate Reduction in Temporal Sensory Summation after Thoracic Spinal Manipulation. Spine J. 2011, 11, 440–446. [Google Scholar] [CrossRef]
- Aspinall, S.L.; Jacques, A.; Leboeuf-Yde, C.; Etherington, S.J.; Walker, B.F. No Difference in Pressure Pain Threshold and Temporal Summation after Lumbar Spinal Manipulation Compared to Sham: A Randomised Controlled Trial in Adults with Low Back Pain. Musculoskelet. Sci. Pract. 2019, 43, 18–25. [Google Scholar] [CrossRef]
- George, S.Z.; Bishop, M.D.; Bialosky, J.E.; Zeppieri, G., Jr.; Robinson, M.E. Immediate Effects of Spinal Manipulation on Thermal Pain Sensitivity: An Experimental Study. BMC Musculoskelet. Disord. 2006, 7, 68. [Google Scholar] [CrossRef] [PubMed]
- Nim, C.; Kawchuk, G.; Schiøttz-Christensen, B.; O’Neill, S. The Effect on Clinical Outcomes When Targeting Spinal Manipulation at Stiffness or Pain Sensitivity: A Randomized Trial. Sci. Rep. 2020, 10, 14615. [Google Scholar] [CrossRef]
- Bialosky, J.E.; Beneciuk, J.M.; Bishop, M.D.; Coronado, R.A.; Penza, C.W.; Simon, C.B.; George, S.Z. Unraveling the Mechanisms of Manual Therapy: Modeling an Approach. J. Orthop. Sports Phys. Ther. 2018, 48, 8–18. [Google Scholar] [CrossRef] [PubMed]
- Farra, F.D.; Bergna, A.; Lunghi, C.; Bruini, I.; Galli, M.; Vismara, L.; Tramontano, M. Reported Biological Effects Following Osteopathic Manipulative Treatment: A Comprehensive Mapping Review. Complement. Ther. Med. 2024, 82, 103043. [Google Scholar] [CrossRef] [PubMed]
- Colloca, L.; Klinger, R.; Flor, H.; Bingel, U. Placebo Analgesia: Psychological and Neurobiological Mechanisms. Pain 2013, 154, 511–514. [Google Scholar] [CrossRef]
- Colloca, L.; Grillon, C. Understanding Placebo and Nocebo Responses for Pain Management. Curr. Pain Headache 2014, 18, 419. [Google Scholar] [CrossRef]
- Shi, Y.; Cui, S.; Zeng, Y.; Huang, S.; Cai, G.; Yang, J.; Wu, W. Brain Network to Placebo and Nocebo Responses in Acute Experimental Lower Back Pain: A Multivariate Granger Causality Analysis of FMRI Data. Front. Behav. Neurosci. 2021, 15, 696577. [Google Scholar] [CrossRef]
- Anderson, S.; Stebbins, G.T. Determinants of Placebo Effects. Int. Rev. Neurobiol. 2020, 153, 27–47. [Google Scholar] [CrossRef]
- Hartmann, H.; Banwinkler, M.; Riva, F.; Riva, F.; Lamm, C. To Respond or Not to Respond: Exploring Empathy-Related Psychological and Structural Brain Differences between Placebo Analgesia Responders and Non-Responders. Front. Psychol. 2023, 14, 1257522. [Google Scholar] [CrossRef]
- Blasini, M.; Peiris, N.; Wright, T.; Colloca, L. The Role of Patient-Practitioner Relationships in Placebo and Nocebo Phenomena. Int. Rev. Neurobiol. 2018, 139, 211–231. [Google Scholar] [CrossRef]
- Testa, M.; Rossettini, G. Enhance Placebo, Avoid Nocebo: How Contextual Factors Affect Physiotherapy Outcomes. Man. Ther. 2016, 24, 65–74. [Google Scholar] [CrossRef] [PubMed]
- Testa, M.; Rossettini, G.; Barbiani, D.; Miciak, M. Management of Contextual Factors to Enhance Placebo and Minimize Nocebo Effects in Clinical Practice. In Placebo Effects Through the Lens of Translational Research; Colloca, L., Ed.; Oxford Academic: New York, NY, USA, 2023; pp. 275–C5.3P89. [Google Scholar]
- Cundiff-O’Sullivan, R.; Oula, D.; Shafir, R.; Colloca, L. Cultural Influences on Placebo and Nocebo Effects. In Placebo Effects Through the Lens of Translational Research; Colloca, L., Noel, J., Franklin, P.D., Seneviratne, C., Eds.; Oxford Academic: New York, NY, USA, 2023. [Google Scholar]
- Bieniek, H.; Bąbel, P. Placebo Hypoalgesia Induced by Operant Conditioning: A Comparative Study on the Effects of Verbal, Token-Based, and Social Rewards and Punishers. Sci. Rep. 2023, 13, 20346. [Google Scholar] [CrossRef] [PubMed]
- Meeuwis, S.H.; Wasylewski, M.T.; Bajcar, E.A.; Bieniek, H.; Adamczyk, W.M.; Honcharova, S.; Nardo, M.; Mazzoni, G.; Bąbel, P. Learning Pain from Others: A Systematic Review and Meta-Analysis of Studies on Placebo Hypoalgesia and Nocebo Hyperalgesia Induced by Observational Learning. Pain 2023, 164, 2383–2396. [Google Scholar] [CrossRef] [PubMed]
- Eippert, F.; Bingel, U.; Schoell, E.D.; Yacubian, J.; Klinger, R.; Lorenz, J.; Büchel, C. Activation of the Opioidergic Descending Pain Control System Underlies Placebo Analgesia. Neuron 2009, 63, 533–543. [Google Scholar] [CrossRef]
- Schweinhardt, P.; Seminowicz, D.A.; Jaeger, E.; Duncan, G.H.; Bushnell, M.C. The Anatomy of the Mesolimbic Reward System: A Link between Personality and the Placebo Analgesic Response. J. Neurosci. 2009, 29, 4882–4887. [Google Scholar] [CrossRef]
- Walach, H. Placebo Effects in Complementary and Alternative Medicine: The Self-Healing Response. In Placebo and Pain: From Bench to Bedside; Colloca, L., Flaten, M.A., Meissner, K., Eds.; Academic Press: New York, NY, USA, 2013; pp. 189–202. [Google Scholar]
- Hróbjartsson, A.; Gøtzsche, P.C. Placebo Interventions for All Clinical Conditions. Cochrane Database Syst. Rev. 2010, 3974. [Google Scholar] [CrossRef]
- Ashar, Y.K.; Chang, L.J.; Wager, T.D. Brain Mechanisms of the Placebo Effect: An Affective Appraisal Account. Annu. Rev. Clin. Psychol. 2017, 13, 73–98. [Google Scholar] [CrossRef]
- Beedie, C.; Whyte, G.; Lane, A.M.; Cohen, E.; Raglin, J.; Hurst, P.; Coleman, D.; Foad, A. Caution, This Treatment Is a Placebo. It Might Work, but It Might Not’: Why Emerging Mechanistic Evidence for Placebo Effects Does Not Legitimise Complementary and Alternative Medicines in Sport. Br. J. Sports Med. 2018, 52, 817–818. [Google Scholar] [CrossRef]
- Wager, T.D.; Atlas, L.Y. The Neuroscience of Placebo Effects: Connecting Context, Learning and Health. Nat. Rev. Neurosci. 2015, 16, 403–418. [Google Scholar] [CrossRef]
- Thomson, O.; Rossettini, G. Don’t Focus on the Finger, Look at the Moon’—The Importance of Contextual Factors for Clinical Practice and Research. Int. J. Osteopath. Med. 2021, 40, 1–3. [Google Scholar] [CrossRef]
- Pedersen, J.R.; Strijkers, R.; Gerger, H.; Koes, B.; Chiarotto, A. Clinical Improvements Due to Specific Effects and Placebo Effects in Conservative Interventions and Changes Observed with No Treatment in Randomized Controlled Trials of Patients with Chronic Nonspecific Low Back Pain: A Systematic Review and Meta-Analysi. Pain 2024, 165, 1217–1232. [Google Scholar] [CrossRef]
- Caliskan, E.B.; Bingel, U.; Kunkel, A. Translating Knowledge on Placebo and Nocebo Effects into Clinical Practice. PAIN Rep. 2024, 9, 1142. [Google Scholar] [CrossRef] [PubMed]
- Benedetti, F.; Thoen, W.; Blanchard, C.; Vighetti, S.; Arduino, C. Pain as a Reward: Changing the Meaning of Pain from Negative to Positive Co-Activates Opioid and Cannabinoid Systems. Pain 2013, 154, 361–367. [Google Scholar] [CrossRef]
- Honda, K.; Jacobson, J.S. Use of Complementary and Alternative Medicine among United States Adults:The Influences of Personality, Coping Strategies, and Social Support. Prev. Med. 2005, 40, 46–53. [Google Scholar] [CrossRef] [PubMed]
- Esteves, J.E.; Cerritelli, F.; Kim, J.; Friston, K.J. Osteopathic Care as (En)Active Inference: A Theoretical Framework for Developing an Integrative Hypothesis in Osteopathy. Front. Psychol. 2022, 13, 812926. [Google Scholar] [CrossRef] [PubMed]
- Moreno-Castro, C.; Corell-Doménech, M.; Camano-Puig, R. Which Has More Influence on Perception of Pseudo-Therapies: The Media’s Information, Friends or Acquaintances Opinion, or Educational Background? Commun. Soc. 2019, 32, 35. [Google Scholar] [CrossRef]
- Blanco, F. Cognitive Bias. In Encyclopedia of Animal Cognition and Behavior; Vonk, J., Shackelford, T., Eds.; Springer: Cham, Switzerland, 2017. [Google Scholar]
- Torres, M.N.; Barberia, I.; Rodríguez-Ferreiro, J. Causal Illusion in the Core of Pseudoscientific Beliefs: The Role of Information Interpretation and Search Strategies. PLoS ONE 2022, 17, 272201. [Google Scholar] [CrossRef]
- Yarritu, I.; Matute, H. Previous Knowledge Can Induce an Illusion of Causality through Actively Biasing Behavior. Front. Psychol. 2015, 6, 389. [Google Scholar] [CrossRef]
- Chow, J.Y.L.; Colagiuri, B.; Rottman, B.M.; Goldwater, M.; Livesey, E.J. Pseudoscientific Health Beliefs and the Perceived Frequency of Causal Relationships. Int. J. Environ. Res. Public Health 2021, 18, 11196. [Google Scholar] [CrossRef]
- Rodríguez-Ferreiro, J.; Barberia, I. Believers in Pseudoscience Present Lower Evidential Criteria. Sci. Rep. 2021, 11, 24352. [Google Scholar] [CrossRef]
- Garcia-Arch, J.; Barberia, I.; Rodríguez-Ferreiro, J.; Fuentemilla, L. Authority Brings Responsibility: Feedback from Experts Promotes an Overweighting of Health-Related Pseudoscientific Beliefs. Int. J. Environ. Res. Public Health 2022, 19, 15154. [Google Scholar] [CrossRef] [PubMed]
- Winslow, L.C.; Shapiro, H. Physicians Want Education about Complementary and Alternative Medicine to Enhance Communication with Their Patients. Arch. Intern. Med. 2002, 162, 1176–1181. [Google Scholar] [CrossRef] [PubMed]
- García-Arch, J.; Ballestero-Arnau, M.; Hoyas, L.P.; Giaiotti, F. Disproven but Still Believed: The Role of Information and Individual Differences in the Prediction of Topic-Related Pseudoscience Acceptance. Appl. Cogn. Psychol. 2022, 36, 2. [Google Scholar] [CrossRef]
- Pérez, R.P.; Cuadros, E.N.; García, L.C.; López, I.D.; Fernández, R.E.; Gil Lemus, M.Á.; Blanco, S.M.; Marrodán, B.R.; Calvo, C. Results of a National Survey on Knowledge and Use of Complementary and Alternative Medicine by Paediatricians. An. Pediatr. 2022, 96, 25–34. [Google Scholar] [CrossRef]
- Klein, C.T.; Helweg-Larsen, M. Perceived Control and the Optimistic Bias: A Meta-Analytic Review. Psychol. Health 2002, 17, 437–446. [Google Scholar] [CrossRef]
- Galbraith, N.; Moss, T.; Galbraith, V.; Purewal, S. A Systematic Review of the Traits and Cognitions Associated with Use of and Belief in Complementary and Alternative Medicine (CAM). Psychol. Health Med. 2018, 23, 854–869. [Google Scholar] [CrossRef]
- Singh, H.; Maskarinec, G.; Shumay, D.M. Understanding the Motivation for Conventional and Complementary/Alternative Medicine Use among Men with Prostate Cancer. Integr. Cancer Ther. 2005, 4, 187–194. [Google Scholar] [CrossRef]
- Shih, V.; Chiang, J.Y.L.; Chan, A. Complementary and Alternative Medicine (CAM) Usage in Singaporean Adult Cancer Patients. Ann. Oncol. 2009, 20, 752–757. [Google Scholar] [CrossRef]
- Forer, B.R. The Fallacy of Personal Validation: A Classroom Demonstration of Gullibility. J. Abnorm. Soc. Psychol. 1949, 44, 118–123. [Google Scholar] [CrossRef]
- Kaptchuk, T.J. The Placebo Effect in Alternative Medicine: Can the Performance of a Healing Ritual Have Clinical Significance? Ann. Intern. Med. 2002, 136, 817. [Google Scholar] [CrossRef]
- Davies, K.; Heinsch, M.; Tickner, C.; Brosnan, C.; Steel, A.; Patel, G.; Marsh, M. Classifying Knowledge Used in Complementary Medicine Consultations: A Qualitative Systematic Review. BMC Complement. Med. Ther. 2022, 22, 212. [Google Scholar] [CrossRef]
- Stub, T.; Foss, N.; Liodden, I. Placebo Effect Is Probably What We Refer to as Patient Healing Power”: A Qualitative Pilot Study Examining How Norwegian Complementary Therapists Reflect on Their Practice. BMC Complement. Altern. Med. 2017, 17, 262. [Google Scholar] [CrossRef] [PubMed]
- Garrett, B.; Mallia, E.; Anthony, J. Public Perceptions of Internet-Based Health Scams, and Factors That Promote Engagement with Them. Health Soc. Care Community 2019, 27, 672–686. [Google Scholar] [CrossRef] [PubMed]
- Sperber, D. The Guru Effect. Rev. Philos. Psychol. 2010, 1, 583–592. [Google Scholar] [CrossRef]
- Berthelot, J.M.; Le Goff, B.; Maugars, Y. The Hawthorne Effect: Stronger than the Placebo Effect? Jt. Bone Spine 2011, 78, 335–336. [Google Scholar] [CrossRef]
- Wolfe, F.; Michaud, K. The Hawthorne Effect, Sponsored Trials, and the Overestimation of Treatment Effectiveness. J. Rheumatol. 2010, 37, 2216–2220. [Google Scholar] [CrossRef]
- Neogi, T.; Colloca, L. Placebo Effects in Osteoarthritis: Implications for Treatment and Drug Development. Nat. Rev. Rheumatol. 2023, 19, 613–626. [Google Scholar] [CrossRef]
- Beyerstein, B.L. Alternative Medicine and Common Errors of Reasoning. Acad. Med. 2001, 76, 230–237. [Google Scholar] [CrossRef]
- Vicente, L.; Blanco, F.; Matute, H. I Want to Believe: Prior Beliefs Influence Judgments about the Effectiveness of Both Alternative and Scientific Medicine. Judgm. Decis. Mak. 2023, 18, 1. [Google Scholar] [CrossRef]
- Rossettini, G.; Carlino, E.; Testa, M. Clinical Relevance of Contextual Factors as Triggers of Placebo and Nocebo Effects in Musculoskeletal Pain. BMC Musculoskelet. Disord. 2018, 19, 27. [Google Scholar] [CrossRef]
- Calpin, P.; Imran, A.; Harmon, D. A Comparison of Expectations of Physicians and Patients with Chronic Pain for Pain Clinic Visits. Pain Pract. 2017, 17, 305–311. [Google Scholar] [CrossRef] [PubMed]
- Fulda, K.G.; Slicho, T.; Stoll, S.T. Patient Expectations for Placebo Treatments Commonly Used in Osteopathic Manipulative Treatment (OMT) Clinical Trials: A Pilot Study. Osteopath. Med. Prim. Care 2007, 1, 3. [Google Scholar] [CrossRef]
- Bialosky, J.E.; Bishop, M.D.; Price, D.D.; Robinson, M.E.; George, S.Z. The Mechanisms of Manual Therapy in the Treatment of Musculoskeletal Pain: A Comprehensive Model. Man. Ther. 2009, 14, 531–538. [Google Scholar] [CrossRef] [PubMed]
- Meissner, K.; Fässler, M.; Rücker, G.; Kleijnen, J.; Hróbjartsson, A.; Schneider, A.; Antes, G.; Linde, K. Differential Effectiveness of Placebo Treatments: A Systematic Review of Migraine Prophylaxis. JAMA Intern. Med. 2013, 173, 1941–1951. [Google Scholar] [CrossRef] [PubMed]
- Nim, C.; Aspinall, S.; Cook, C.; Corrêa, L.; Donaldson, M.; Downie, A.; Juhl, C. The Effectiveness of Spinal Manipulative Therapy in Treating Spinal Pain Does Not Depend on the Application Procedures: A Systematic Review and Network Meta-Analysis. J. Orthop. Sports Phys. Ther. 2025, 55, 75–161. [Google Scholar] [CrossRef]
- Cerritelli, F.; Verzella, M.; Cicchitti, L.; D’alessandro, G.; Vanacore, N. The Paradox of Sham Therapy and Placebo Effect in Osteopathy: A Systematic Review. Medicine 2016, 95, 4728. [Google Scholar] [CrossRef]
- Paterson, C.; Dieppe, P. Characteristic and Incidental (Placebo) Effects in Complex Interventions Such as Acupuncture. BMJ 2005, 330, 1202–1205. [Google Scholar] [CrossRef]
- Linde, M.; Fjell, A.; Carlsson, J.; Dahlöf, C. Role of the Needling per Se in Acupuncture as Prophylaxis for Menstrually Related Migraine: A Randomized Placebo-Controlled Study. Cephalalgia 2005, 25, 41–47. [Google Scholar] [CrossRef]
- Diener, H.-C.; Kronfeld, K.; Boewing, G.; Lungenhausen, M.; Maier, C.; Molsberger, A.; Tegenthoff, M.; Trampisch, H.-J.; Zenz, M.; Meinert, R. Efficacy of Acupuncture for the Prophylaxis of Migraine: A Multicentre Randomised Controlled Clinical Trial. Lancet Neurol. 2006, 5, 310–316. [Google Scholar] [CrossRef]
- Tsutsumi, Y.; Tsujimoto, Y.; Tajika, A.; Omae, K.; Fujii, T.; Onishi, A.; Kataoka, Y.; Katsura, M.; Noma, H.; Sahker, E. Proportion Attributable to Contextual Effects in General Medicine: A Meta-Epidemiological Study Based on Cochrane Reviews. BMJ Evid. Based Med. 2023, 28, 40–47. [Google Scholar] [CrossRef]
- Cai, L.; He, L. Placebo Effects and the Molecular Biological Components Involved. Gen. Psychiatry 2019, 32, 100089. [Google Scholar] [CrossRef] [PubMed]
- Rossettini, G.; Campaci, F.; Bialosky, J.; Huysmans, E.; Vase, L.; Carlino, E. The Biology of Placebo and Nocebo Effects on Experimental and Chronic Pain: State of the Art. J. Clin. Med. 2023, 12, 4113. [Google Scholar] [CrossRef]
- Peciña, M.; Zubieta, J.-K. Molecular Mechanisms of Placebo Responses in Humans. Mol. Psychiatry 2014, 20, 416–423. [Google Scholar] [CrossRef] [PubMed]
- Benedetti, F.; Mayberg, H.S.; Wager, T.D.; Stohler, C.S.; Zubieta, J.-K. Neurobiological Mechanisms of the Placebo Effect. J. Neurosci. 2005, 25, 10390–10402. [Google Scholar] [CrossRef] [PubMed]
- Atlas, L.Y.; Wager, T.D. A Meta-Analysis of Brain Mechanisms of Placebo Analgesia: Consistent Findings and Unanswered Questions. Handb. Exp. Pharmacol. 2014, 225, 37–69. [Google Scholar] [CrossRef]
- Amanzio, M.; Benedetti, F.; Porro, C.A.; Palermo, S.; Cauda, F. Activation Likelihood Estimation Meta-Analysis of Brain Correlates of Placebo Analgesia in Human Experimental Pain. Hum. Brain Mapp. 2013, 34, 738–752. [Google Scholar] [CrossRef]
- Eippert, F.; Finsterbusch, J.; Bingel, U.; Büchel, C. Direct Evidence for Spinal Cord Involvement in Placebo Analgesia. Science 2009, 326, 404. [Google Scholar] [CrossRef]
- Crawford, L.S.; Mills, E.P.; Hanson, T.; Macey, P.M.; Glarin, R.; Macefield, V.G.; Keay, K.A.; Henderson, L.A. Brainstem Mechanisms of Pain Modulation: A within-Subjects 7T FMRI Study of Placebo Analgesic and Nocebo Hyperalgesic Responses. J. Neurosci. 2021, 41, 9794–9806. [Google Scholar] [CrossRef]
- Büchel, C.; Geuter, S.; Sprenger, C.; Eippert, F. Placebo Analgesia: A Predictive Coding Perspective. Neuron 2014, 81, 1223–1239. [Google Scholar] [CrossRef]
- Stein, N.; Sprenger, C.; Scholz, J.; Wiech, K.; Bingel, U. White Matter Integrity of the Descending Pain Modulatory System Is Associated with Interindividual Differences in Placebo Analgesia. Pain 2012, 153, 2210–2217. [Google Scholar] [CrossRef]
- Lee, I.-S.; Wallraven, C.; Kong, J.; Chang, D.-S.; Lee, H.; Park, H.-J.; Chae, Y. When Pain Is Not Only Pain: Inserting Needles into the Body Evokes Distinct Reward-Related Brain Responses in the Context of a Treatment. Physiol. Behav. 2015, 140, 148–155. [Google Scholar] [CrossRef]
- Zunhammer, M.; Spisák, T.; Wager, T.D.; Bingel, U.P.I.C. Meta-Analysis of Neural Systems Underlying Placebo Analgesia from Individual Participant FMRI Data. Nat. Commun. 2021, 12, 1391. [Google Scholar] [CrossRef] [PubMed]
- Carrasco-Uribarren, A.; Mamud-Meroni, L.; Tarcaya, G.E.; Jiménez-Del-Barrio, S.; Cabanillas-Barea, S.; Ceballos-Laita, L. Clinical Effectiveness of Craniosacral Therapy in Patients with Headache Disorders: A Systematic Review and Meta-Analysis. Pain Manag. Nurs. 2024, 25, 21–28. [Google Scholar] [CrossRef] [PubMed]
- Rubinstein, S.M.; van Middelkoop, M.; Assendelft, W.J.; de Boer, M.R.; van Tulder, M.W. Spinal Manipulative Therapy for Chronic Low-Back Pain. Cochrane Database Syst. Rev. 2011, 16, CD008112. [Google Scholar]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Mamud-Meroni, L.; Tarcaya, G.E.; Carrasco-Uribarren, A.; Rossettini, G.; Flores-Cortes, M.; Ceballos-Laita, L. “The Dark Side of Musculoskeletal Care”: Why Do Ineffective Techniques Seem to Work? A Comprehensive Review of Complementary and Alternative Therapies. Biomedicines 2025, 13, 392. https://doi.org/10.3390/biomedicines13020392
Mamud-Meroni L, Tarcaya GE, Carrasco-Uribarren A, Rossettini G, Flores-Cortes M, Ceballos-Laita L. “The Dark Side of Musculoskeletal Care”: Why Do Ineffective Techniques Seem to Work? A Comprehensive Review of Complementary and Alternative Therapies. Biomedicines. 2025; 13(2):392. https://doi.org/10.3390/biomedicines13020392
Chicago/Turabian StyleMamud-Meroni, Lucas, Germán E. Tarcaya, Andoni Carrasco-Uribarren, Giacomo Rossettini, Mar Flores-Cortes, and Luis Ceballos-Laita. 2025. "“The Dark Side of Musculoskeletal Care”: Why Do Ineffective Techniques Seem to Work? A Comprehensive Review of Complementary and Alternative Therapies" Biomedicines 13, no. 2: 392. https://doi.org/10.3390/biomedicines13020392
APA StyleMamud-Meroni, L., Tarcaya, G. E., Carrasco-Uribarren, A., Rossettini, G., Flores-Cortes, M., & Ceballos-Laita, L. (2025). “The Dark Side of Musculoskeletal Care”: Why Do Ineffective Techniques Seem to Work? A Comprehensive Review of Complementary and Alternative Therapies. Biomedicines, 13(2), 392. https://doi.org/10.3390/biomedicines13020392